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DNA origami has emerged over the past decade as a promising technology for the 
synthesis and study of matter at the nanoscale, with applications in a wide variety of fields. 
In this work, we designed and synthesized a DNA origami nanorod capable of providing a 
support scaffold for the precise spatial arrangement of two different components - iron 
oxide magnetic nanoparticles and molecular motor foothold domains. Using this system, 
we are able to demonstrate new functionality of DNA origami nanostructures while 
simultaneously answering questions about the mechanism of MRI contrast enhancement 
with clustered iron oxide nanoparticles and the factors that affect rolling nanoscale 
locomotion. 
In the first part of this thesis, iron oxide nanoparticles are assembled onto our DNA 
nanorod in prescribed patterns to help understand how their spatial organization affects 
MRI contrast generation. Clustering of these nanocrystals has been previously 
demonstrated to increase the efficiency of contrast generation, and thus offers promise as 
a means of synthesizing the next generation of MRI contrast agents. However, current 
techniques for inducing assembly offer limited control over the properties of the final 
superstructure, hindering in-depth mechanistic studies into the nature of this enhancement. 
We designed the DNA origami nanorod to contain binding sites for the iron oxide 
nanoparticles. We demonstrate successful synthesis of DNA-coated particles using the 
'Programmable Atom Equivalent' technique and show successful binding of both these 
particles and streptavidin-modified commercial iron oxide nanoparticles, finding that the 
use of DNA-coated particles produces constructs with much higher yield and purity. This 
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system facilitates the assembly of IONP clusters with precise and independent control over 
both number and spacing - we assemble up to 4 nanoparticles with reasonable yield and 
controlled spacing, and also assemble a pair of particles with spacing between 25 and 125 
nm in ~10 nm increments. Finally, we show that discrete changes in the number of iron 
oxide nanoparticles in a cluster between 1 and 3 leads to enhancement in T2 relaxivity up 
to 20%, while changes in spacing between 40 and 110 nm shows negligible differences. 
Saturating the number of binding sites enables the assembly of ~8-9 nanoparticles and 
produces T2 relaxivity enhancements up to 140%, which is comparable to previous 
clustering techniques. Dimerization of DNA origami-iron oxide nanoparticle constructs 
also facilitates dynamic modulation of T2 MRI contrast, opening up the possibility for 
biosensing applications. 
In the second part of the thesis, we use our DNA origami nanorod to synthesize a 
nanoscale molecular motor which exhibits a unique rolling behavior. These motors exhibit 
super-diffusive motion over several hours with net displacements of several microns and 
velocities up to 200 nm per minute, which are significant improvements over traditional 
DNA walkers.  We tune the exact location of the motor domain strands - by selectively 
decorating only certain sides of the rod, we are able to show that motors which are capable 
of exhibiting a rolling behavior show higher processivity with increased directionality. We 
also find that the density and polyvalency of motor domains plays a large role in controlling 
motion, such that net displacement drops when the density of motor domains drops. 
Finally, we find that the rigidity of the DNA origami rod has an impact on motor behavior, 
with more flexible structures exhibiting less ballistic motion and lower processivity 
compared to rigid motors.  
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The work presented here represents two novel applications of DNA origami 
nanostructures and offer promise as platform technologies for the further development of 







CHAPTER 1. INTRODUCTION 
 Processes that occur at the nanoscale are the foundational building blocks of our 
world. As such, there is considerable interest in ways to study and manipulate matter at this 
scale, with applications in a number of fields including biomedicine. Traditional methods 
for working with nanoscale processes are either are costly and time consuming, such as 
electron beam lithography, or are limited in their scope, such as canonical nanoparticle 
synthesis. DNA nanotechnology has emerged over the past decade as a promising 
technology for bridging this gap, offering the capacity for precise and tunable nanoscale 
synthesis while maintaining the ease and scale of traditional bottom-up self-assembly. 
DNA nanotechnology, and DNA origami in particular, has been used to build nanoscale 
machines with prescribed motions, to organize nanoparticles in order to manipulate light 
propagation, to study the action of individual proteins, and to develop novel drug delivery 
vehicles.   
 The goal of this thesis is to develop novel ways in which DNA origami can be used 
to manipulate nanoscale processes. To this end, we have developed a single DNA origami 
nanorod which is used in two distinct studies, highlighting the multifunctionality of this 
structure. In Chapter 2 I present background information on the field of DNA 
nanotechnology in general and DNA origami in particular, highlighting applications in 
which DNA origami structures have been used to create nanoscale machines and organize 
the assembly of various heteroelements. I also present background on other fields related 




 In Specific Aim 1 (Chapters 3 and 4), I investigated the effect of iron oxide 
nanoparticle (IONP) clustering on MRI contrast generation. After confirming that we can 
induce general clustering using the dual solvent exchange coating technique, we sought to 
use a 16-helix bundle (16HB) DNA origami rod as a scaffold to control the spatial 
orientation of the iron oxide nanoparticles. Our hypothesis was that precise changes in the 
number and spacing of IONPs would lead to changes in T2 relaxivity. We also hypothesized 
that dynamic changes in the DNA origami scaffold would translate to dynamic changes in 
T2 relaxivity. We first designed, synthesized, and characterized a 16HB DNA origami rod, 
followed by the investigation of various methods for attaching IONPs to the 16HB. We 
found DNA-coated IONPs with complementary capture sequences on the DNA origami 
produced the highest quality 16HB-IONP constructs. We next investigated factors 
affecting IONP binding to the 16HB rod while also demonstrating the precise control over 
spacing and number of particles attached to the rod. Finally, we show how the organization 
of the IONPs on the DNA origami affects T2 relaxivity of the system, while also showing 
the dynamic assembly of 16HB dimers leads to alterations in the magnetic signal. 
 In Specific Aim 2 (Chapter 5) we investigated a new application for the same 16HB 
rod - the synthesis of the first DNA origami molecular motor, and the first autonomous 
nanoscale rolling motor of any type. We demonstrate that a structure containing RNA-
binding domains extending from the surface can successfully bind to an RNA-coated 
surface, and that introduction of the nuclease RNase H can induce motion of the 16HB 
along the surface through a burned-bridge Brownian ratchet mechanism. Careful 
engineering of the spatial distribution of the RNA-binding motor domains allows us to 
interrogate the mechanism of locomotion, namely rolling verse walking, as well as to 
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investigate the effects of manipulating motor domain density and polyvalency on motion. 
Finally, we alter the mechanical properties of the motor through the introduction of planned 
defects to investigate the effect of rigidity on the efficiency and directionality of movement. 
 Combined, this work demonstrates two novel applications for DNA origami 
nanostructures. We expect this work will serve as an initial platform for further studies into 
these phenomena and open up a range of new possibilities for the use of structural DNA 
nanotechnology as MRI contrast agents and theranostic drug delivery agents, as well as 




CHAPTER 2. BACKGROUND 
This chapter contains background on the 3 main components of this thesis: DNA 
nanotechnology, which is the technique used predominately throughout the thesis; 
Magnetic Nanoparticles and MRI, the basis for Specific Aim 1; Molecular Motors, which 
is the basis for Specific Aim 2. 
2.1 DNA Nanotechnology and DNA Origami 
This section will cover some brief details on the DNA origami technique as well as 
an overview of functional uses of these structures in the literature. Much of this information 
was covered in a review paper I wrote, and several passages were quoted verbatim from 
that article[1]. Over the past three decades, deoxyribonucleic acid (DNA), the genetic 
carrier of information in most living organisms, has seen an ever-expanding role as a 
material for the construction of nanoscale objects [2-4]. The field of structural DNA 
nanotechnology dates back to the early 1980’s, when Nadrian Seeman hypothesized that 
structurally-rigid branched DNA constructs, analogous to Holliday Junction structures 
found in biology, could be used as a material for the construction of nanoscale structures 
[5]. DNA has several useful characteristics for a construction material; it is a chemically 
stable biomolecule with a well-defined structure and appealing mechanical properties[2]. 
Furthermore, the highly specific molecular recognition capability of DNA, mediated by 
Watson-Crick base-pairing, enables the programmed self-assembly of a large number of 
unique DNA sequences into well-defined higher-order architectures. The relatively 
simplistic nature of DNA, both from a structural and recognition stand-point, makes de 
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novo design of DNA nanostructures feasible compared to more complex protein 
assemblies. 
 
Figure 2-1: Schematic of DNA Origami Assembly. DNA origami structures are 
produced by annealing a long scaffold strand with many short synthetic staple strands, 
producing a nanostructure consisting of multiple DNA double-helices linked together into 
arbitrary shapes. 
 
 DNA nanostructures have gradually increased in complexity over the past 3 
decades, from a simple cube with a single double helical edges[6]  to massive, arbitrarily-
prescribed shapes formed from over 400 unique oligonucleotides[7]. A major breakthrough 
in structural DNA nanotechnology came in 2006 with the development of DNA origami 
by Paul Rothemund[8]. DNA origami is a process of molecular self-folding: a long single-
stranded DNA (scaffold), typically M13 phage genomic DNA (~7000 bases), is folded into 
prescribed objects by hundreds of short synthetic DNA oligonucleotide “staple strands”, 
typically 20-60 bases long, which are designed to be complementary to different parts of 
the scaffold DNA (Figure 2-1). Each staple strand consists of several domains which are 
complementary to linearly distant regions within the scaffold strand - hybridization of these 
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domains brings the regions into close proximity in 3D space. Staple strands are designed 
to cross-over between neighboring duplexes, effectively ‘stapling’ individual helices into 
larger helical bundles (HB). Full details on the principles of DNA origami design are not 
particularly relevant to this work but readers are encouraged to look at several excellent 
review articles for a comprehensive elaboration [9, 10].  
In the first report of DNA origami planar, arbitrary-shaped, two-dimensional (2D) 
objects with length scales around 100 nm were constructed [8]. Simple 3D hollow 
containers were constructed in 2009 via the folding of 2D planar DNA origami sheets, such 
as a tetrahedron[11] and a cube [12]. A milestone advancement in constructing 3D origami 
structures was introduced by Shih and coworkers in 2009, in which DNA helices are 
bundled into a honeycomb lattice to construct solid 3D objects [13]. To simply the design 
process and enable a general route for the rapid design of sophisticated shapes, they 
developed the caDNAno software[14]. The Shih group later on demonstrated square [15] 
and hybrid lattice[16] [17] design concepts. Subsequent work enabled the introduction of 
curvature by simply adding or deleting bases between adjacent DNA helical crossovers 
[17]. In a departure from the traditional rigid lattice model, a study published in 2011 by 
Yan and coworkers used concentric DNA rings to define the surface feature of 3D objects, 
inducing curvature through the manipulation of strand crossover positions[18].  
2.1.1 DNA Origami for Nanofabrication 
The DNA origami technique has been used extensively for the fabrication of 
nanoscale constructs, including many that are unobtainable (or extremely difficult to 
obtain) with other approaches. At the macroscopic scale, top-down fabrication of materials 
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is used to create products with specific structures and functions. Unfortunately, this same 
capability has been difficult to achieve on the nanoscale, as bottom-up self-assembly 
methods suffer from limited scope due to thermodynamic constraints and top-down 
methods are time-consuming and costly. DNA origami helps to bridge this fabrication gap, 
as the ability to self-assemble arbitrary shapes with full addressability allows for the 
fabrication of nanostructures with well-defined form and the capacity to precisely arrange 
heteroelements. A particularly appealing aspect of DNA origami is the global 
addressability - the use of a unique scaffold strand in DNA origami means that the relative 
spatial location of every single base-pair is known with nanometer precision. This creates 
a molecular “breadboard”, in which guest species can be organized in arbitrary patterns 
and arrangements on the DNA origami surface. This capacity for precision nanofabrication 
has positioned DNA origami nanostructures as an excellent platform for studying the 
effects of spatial organization on interactions between various heteroelements.  
Heteroelements are typically incorporated into DNA origami nanostructures 
through modifications to select staple strands. The most common option is to use modified 
staple strands in which a unique ‘capture’ sequence extends as a free, single-stranded 
protrusion. Heteroelements modified with oligonucleotides bearing the complementary 
sequence are docked at that location through hybridization. Chemical modifications to 
staple strands are also used – biotinylated staple strands are frequently used to facilitate the 
docking of streptavidin-modified heteroelements, for example. By selectively designing 
which staple strands are chemically modified or contain ‘capture’ extensions, the position 
of other molecular species can be organized. 
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DNA origami has been used for the construction of functional structures consisting 
entirely of DNA, as well as template structures for the organization of both synthetic 
nanomaterial components as well as biomolecules, as molds for nanoparticle synthesis, as 
masks for nanolithography, and as scaffolds for artificial enzyme cascades, etc. The devices 
fabricated using these techniques have been utilized for many applications, including 
nanoplasmonics, nanophotonics, biosensing, and drug delivery.  
2.1.1.1 Nanofabrication of DNA Constructs 
That form dictates function, a governing principle of the natural world, is as true at 
the nanoscale as it is in other areas. Controlling the form of nanostructures enables the 
control of the functions of these particles. For DNA origami, the ability to tune the precise 
shape/size of nanoscale features while also controlling the spatial organization of sequence-
specific DNA strands has enabled the construction of a wide variety of functional DNA 
origami nanostructures. One of the best examples of this comes from the work of Hiroshi 
Sugiyama’s group, who developed a single DNA origami chip that has been used to study 
many different single-molecule processes. The authors designed a 2D rectangular DNA 
origami structure with a square hole in the center, which they call a “DNA frame” [19]. 
Four different ssDNA extensions extend into the middle of the hole, providing anchoring 
points for loading various DNA cargo. The DNA origami frame allows for easy 
identification of structures using atomic force microscopy (AFM) imaging and added 
stability to the cargo, while the hole in the center facilitates high resolution AFM imaging 
by limiting the amount of background near the targets. This chip has been used to study a 
wide variety of nanoscale processes with high-speed AFM, including  transcription factor 
binding[20], photoresponsive DNA elements[21], DNA repair[22], Cre-lox 
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recombination[23], CRISPR-Cas9 activity[24], G-quadruplex formation [25-28], B-Z form 
DNA transitions[29], and much more. AFM imaging and 2D DNA nanostructures have 
also been used for biosensing applications - in this case, the identity of bound species 
visualized under AFM can be determined either through the introduction of indexing 
elements such as DNA dumbbells[30] or through the use of asymmetric DNA 
structures[31]. 
 3D DNA origami structures with specific form/function relationships have also 
been designed, often times with some form of dynamic elements. Shih and Bellot et al. 
created a trapezoidal “nanoactuator” in which the incorporation of additional DNA 
oligonucleotides could force the trapezoid into either “closed” or “open” 
conformations[32]. As an example of how this conformational transition could be used, the 
authors conjugated two halves of a split Enhanced Green Fluorescent Protein (EGFP) to 
either side of the nanoactuator in order to regulate the distance between the EGFP halves - 
increased fluorescence was only observed in the closed conformation. Kuzuya et al 
constructed a reconfigurable "plier"-like DNA origami structure, which facilitated the 
detection of solution-phase binding events through binding-induced switching in the plier 
conformation [33, 34]. Carlos Castro's group has developed numerous dynamic DNA 
origami elements designed to behave like macro-scale mechanical implements, including 
sliding and rotational joints, which can be combined to create more complex motion [35].  





2.1.1.2 Nanofabrication with Synthetic Nanoparticle Heteroelements 
A wide variety of nanomaterials can interface with DNA using a range of 
conjugation techniques, which have been well summarized in a previous review[38]. By 
far the most common material used for nanofabrication with DNA origami is gold. Gold 
nanoparticles (AuNPs) and nanorods (AuNRs) have very interesting optical properties that 
can be modulated through inter-particle interactions. Furthermore, AuNPs can be easily 
incorporated into DNA nanostructures using the facile conjugation of thiolated-
oligonucleotides with the gold surface. There are a vast number of examples in the 
literature of nanofabrication using AuNPs, but only a few representative studies will be 
highlighted here. Recent work by Oleg Gang’s group have demonstrated the ability for 
DNA origami nanostructures to program the fabrication of well-defined two-dimensional 
networks of AuNPs[39]. The authors used a cross-shaped origami tile with a hole in the 
center for capturing a single AuNP. The four edges of the tile were modified with unique 
ssDNA extensions to allow for a wide range of anisotropic and specific connections 
between different tiles in a lock-and-key mechanism. The authors used this system to 
fabricate well-defined AuNP clusters and chains, as well as large 2D arrays. The same 
group has also used three-dimensional polyhedral DNA origami nanostructures to 
construct well-defined 3D AuNP crystal structures [40, 41]. Other groups have explored 
similar gold nanoparticle arrays, including the use of hexagonal tiles[42] and “nano-
flowers"[43] to construct linear chains as well as hexagonal and square lattices.  
The prevailing rationale for using DNA nanostructures to organize AuNPs is the 
ability to use interactions between the nanoparticles as a means of manipulating light. This 
was elegantly demonstrated by Liedl et al., who used a 24-helix bundle DNA origami rod 
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to pattern the self-assembly of AuNPs into helices with either a right-handed or left-handed 
pitch [44]. These nanostructures exhibit pronounced circular dichroism effects in the 
visible range of the electromagnetic spectrum that change based on the helicity of the 
organized AuNPs. Subsequent work by the same group demonstrated switchable circular 
dichroism using a similar DNA origami rod-based architecture, where the orientation of 
the superstructure in reference to incident light could be controlled[45]. Other groups have 
similarly used DNA origami to control the plasmonic behavior of AuNRs, including a 
AuNR capable of walking along a DNA origami track[46], stacked-arrangements of offset 
AuNRs [47], chiral AuNP rings [48],  and the fabrication of static [49] and dynamic [50] 
AuNR dimers.   
The fabrication of devices where AuNPs interact with other optically active 
materials has also been accomplished using DNA origami. In their pioneering work, 
Tinnefeld et al. demonstrated that a zepto-liter electromagnetic “hot spot” could be 
constructed by organizing 100 nm AuNP dimers on a 12-helix bundle DNA origami 
pillar[51]. When the authors placed a fluorescent dye in the gap between the AuNPs, they 
demonstrated fluorescence enhancements of up to 117-fold. By using this system, the 
authors were able to monitor DNA hybridization and Holliday Junction conformational 
dynamics at the single-molecule level. Similar studies have been conducted by other 
groups, including distance-dependent quenching/enhancement effects of fluorescent dye-
gold nanoparticle systems on a triangular DNA origami tile[52] as well as “nano-antennas” 
for hot spot-induced enhancement of surface-enhanced Raman spectroscopy[53]. 
AuNP/quantum dot heteroelement devices have also been constructed to study the 
distance-dependent fluorescence quenching between the two elements[54]. Similar work 
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from the Liedl group investigated the fluorescence life-time of quantum dot-AuNP pairs 
on a DNA origami frame[55]. 
2.1.1.3 Nanofabrication with Biological Heteroelements 
In biology, the spatial arrangement of proteins into large supra-molecular 
complexes leads to enhanced activity or new functionality, particularly in regard to multi-
enzyme pathways. The ability to mimic these complexes through nanofabrication with 
DNA origami is a useful tool to better understand native multi-protein systems, as well as 
to construct more efficient enzymatic nanoreactors for technical applications. While 
simpler DNA nanostructures had been previously used to assemble multi-enzyme systems, 
Yan et al. were the first to use DNA origami to scaffold a more complex, three-protein 
system[56]. Using a two-dimensional rectangular DNA origami tile, the authors were able 
to investigate the effects of protein distance on a glucose oxidase/horseradish peroxidase 
bi-enzymatic process. The authors found that if a non-enzymatic “bridge” protein was 
placed in between the two enzymes the reaction rate could be increased even further. The 
authors attributed this effect to the more effective “shuttling” of reaction intermediates 
between the hydration shells of the two enzymes. Subsequent studies by the same group 
increased the complexity of the design, utilizing a flexible ssDNA linker modified with 
cofactor NAD+ to control the preference for two competing enzymatic reactions[57]. 
Three-dimensional DNA origami nanostructures have also been used to modulate and 
study enzymatic behavior, including the use of a “nanocage” to encapsulate multiple 
enzymes to improve reaction efficiency[58]. 
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DNA origami nanostructures have also been used to control and study non-
enzymatic proteins. Shih and Reck-Peterson et al. used a 12-helix bundle DNA origami 
tube as a platform for organizing the motor proteins kinesin and dynein[59]. Using single-
molecule fluorescence techniques to track the DNA nanostructure, the authors were able 
to study the interplay between motor proteins with opposite-polarity movement. Hogberg 
and Teixeira et al. also used a tubular DNA origami structure to pattern proteins, focusing 
on understanding how the spatial organization of ligands affects receptor-mediated cell 
responses[60]. By controlling the distance between two Ephrin-A2 molecules, the authors 
were able to show how ligand placement alters receptor EphA2 phosphorylation and 
subsequent cell invasion.   
2.2 Magnetic Resonance Imaging and Iron Oxide Nanoparticles 
2.2.1 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) was developed in 1973 and 1974 by Paul 
Lauterber and Peter Mansfield, based on the principle of nuclear magnetic resonance 
(NMR) [61, 62]. Since that time, MRI machines have become a staple in clinics around the 
world and are an essential part of modern healthcare as a means of studying and diagnosing 
a wide variety of injuries and pathologies. MRI has numerous advantages which make it 
well suited as a clinical diagnostic imaging technique – it uses non-ionizing radiation 
(unlike x-ray and CT imaging), so it is considered safer than other imaging modalities; it 
has a large depth of penetration, allowing the visualization of structures and organs deep 
within the body; contrast arises due to variations in the chemical environment of hydrogen 
protons (water) and thus all tissues in the body contribute to the signal, enabling the 
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visualization of soft organs such as the brain, muscles, liver, etc. Relative to other imaging 
techniques, MRI has relatively high spatial resolution, though relatively poor temporal 
resolution. 
MRI works on the principles of nuclear magnetic resonance and is a method by 
which NMR signals can be obtained throughout the body and then reconstructed into two-
dimensional (2D) and three-dimensional (3D) images. Protons have a spin angular 
momentum, and as charged particles, thus have a magnetic moment. In the presence of an 
external magnetic field, such as that provided by the magnetic in an MRI scanner, the 
magnetic moments of protons align with the magnetic field and precess around this axis at 
the Larmor frequency, which can be described by the following equation, where 𝜔𝜔 is the 
Larmor frequency, 𝛾𝛾 is the gyromagnetic ratio, and 𝐵𝐵0 is the strength of the external static 
magnetic field: 
𝜔𝜔 =  𝛾𝛾𝐵𝐵0 
This frequency is unique to nuclei of different atoms, and thus can be used to isolate 
individual elements – while other atoms can contribute to NMR signals, MRI 
predominately focuses on imaging H1 protons due to their abundant prevalence in the body. 
The equilibrium of all hydrogen protons aligning with and precessing about the external 
magnetic field can then be disturbed through the application of a radio-frequency (RF) 
pulse. Photons of the appropriate energy are absorbed by the protons, and this energy 
rotates the magnetic moments of protons away from the longitudinal axis set by the external 
magnetic field, producing both longitudinal and transverse components of the magnetic 
moment. Upon removal of the pulse, the spins relax back to equilibrium through two 
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different mechanisms: spin-spin and spin-lattice relaxation. Spin-spin relaxation, also 
known as T2 relaxation, leads to the loss of the transverse component of the magnetization 
vector. In this case, all the individual protons within a region experience slightly different 
external magnetic fields due to the different chemical environments, and thus precess at 
slightly different frequencies. This leads to a loss of phase coherence (dephasing) and a 
concomitant decrease the net transverse magnetization vector. This relaxation process is 
described by the following equation, where MTR is the transverse magnetization vector, 
M0sin(α) is the magnetization vector in the transverse plane immediately following a RF 
pulse, and T2 is a characteristic time constant which describes the signal decay: 
𝑀𝑀𝑇𝑇𝑇𝑇(𝑡𝑡) = 𝑀𝑀0sin (𝛼𝛼)𝑒𝑒(−𝑡𝑡/𝑇𝑇2) 
Spin-lattice relaxation, or T1 relaxation, is the phenomenon that leads to the 
recovery of the longitudinal component of the magnetization vector. In this case, 
interactions of protons with the neighboring environment (lattice) leads to a transfer of 
energy in the form of heat. This allows the protons to return to their lowest energy state, 
which is aligned with the external magnetic field (maximal longitudinal component, zero 
transverse component). This process is defined by the following equation, where Ml is the 
longitudinal component of the magnetization vector, M0 is the equilibrium magnetization 
vector, and T1 is a characteristic time constant which describes the signal decay: 
𝑀𝑀𝑙𝑙(𝑡𝑡) = 𝑀𝑀0(1 − 𝑒𝑒
�− 𝑡𝑡𝑇𝑇1�) 
Contrast between different tissues arises from differences in the values of T1 and 
T2. For example, cerebral spinal fluid (CSF) has T1 ~ 3000ms and T2 ~ 2000ms, while fat 
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has T1 ~ 200ms and T2 ~100ms. Thus, at any given time t, the transverse magnetization 
vector will differ depending on the type of tissue, and the magnitude of this vector is 
converted into pixel brightness when rendering the final image (Figure 2-2). Further details 
about MRI, such as RF pulse sequences used to generate different forms of contrast and 
spatial encoding through the use of magnetic field gradients, are outside the scope of this 




Figure 2-2. Mechanism of MRI Contrast Generation. Contrast in MRI images is due to 
differences in the relaxation rate of water protons within tissue. For T2 imaging parameters, 
tissues which have shorter T2 values have signals which decay more rapidly, appearing as 






2.2.2 Contrast Enhanced MRI and Molecular Imaging 
While MRI is incredibly useful for the visualization of numerous tissues and the 
diagnosis of numerous pathologies, the mechanism of contrast generation oftentimes 
makes it difficult to distinguish between regions with relatively similar chemical 
compositions/magnetic properties. This is perhaps most pronounced in the case of solid 
tumors located within other tissues, such as in liver cancer. In this case, the tumor tissue is 
often similar enough to healthy liver tissue that the tumor is indistinguishable on MRI 
images. Additionally, MRI primary provides structural information about anatomy within 
the body and offers no insight into physiologic function or cellular/molecular 
characteristics (complex MRI pulse sequences and data analysis do allow for some limited 
functional information based on dynamic changes in MRI signal). Due to this limitation, 
scientists have developed MRI contrast agents, which are exogenous agents introduced into 
the body that alter the MRI signal in their vicinity and thus produce “artificial” contrast on 
MRI images wherever they are located. In this manner, contrast-enhanced MRI can be used 
to visualize and identify new physiologic or pathologic characteristics based on interactions 
between these features and the contrast agents. Through careful design and engineering of 
these contrast agents, information about cellular and molecular processes within the body 
can be gleaned. For example, by engineering contrast agents to bind to specific proteins 
within the body through recognition elements such as antibodies, aptamers, or receptor 
ligands the presence of these specific proteins can be identified. Similarly, it can be 
possible to engineer dynamic elements into contrast agents, such that their ability to 
modulate MRI contrast can be altered. If this dynamic element is tied to some cellular 
process, such as enzymatic activity, the change in contrast induced by changes in contrast 
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agent can be used to identify the presence of said process. This type of imaging has come 
to be known as molecular imaging, due to the ability to analyze molecular characteristics 
within the body[64]. 
 Two different classes of MRI contrast agents exist, based on the method in which 
they alter the relaxation of the magnetic vectors. The first class of agents as known as T1 
agents and serve to decrease T1 of water protons in their vicinity through a mechanism 
described by inner-sphere theory. These agents lead to a more rapid increase in the 
longitudinal magnetization component and produce hyper-intense, brighter images 
(positive contrast) under T1 imaging parameters. The most well-known and widely used T1 
contrast agents are chelates of the paramagnetic ion gadolinium. The second class of 
agents, and those of interest for this work, is known as T2 agents. These species serve to 
decrease the T2 of water protons in their vicinity through a mechanism described by outer-
sphere theory, leading to enhanced dephasing of the transverse components of magnetic 
moments and creating hypo-intense, dark regions (negative contrast) under T2 imaging 
parameters. Based on outer-sphere theory, water molecules which diffuse into regions near 
the MRI contrast agent experience a slightly different magnetic field due to the magnetic 
moment of the contrast agent. This field inhomogeneity causes these protons to spin at 
different frequencies, leading to accelerated dephasing, a loss of coherence, and a 
shortening of T2. Thus, at any given time the transverse magnetization of voxels with a T2 
contrast agent will be lower and the intensity of the signal measured on the MRI will be 
lower. The efficacy of T2 contrast agents is typically quantified using the T2 relaxivity, or 
r2, which corresponds to increases in the rate of T2 shortening per unit concentration of the 
nanoparticles (typically expressed in units of s-1 mM iron-1). Contrast agents with a higher 
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r2 are more effective at shortening T2, producing greater contrast enhancement at lower 
doses. Most T2 contrast agents are magnetic nanoparticles, and their ability to alter T2 is 
expressed by the following equation, where b is a constant that depends on the nature of 
the nanoparticle and the diffusion coefficient, Cx is the concentration of the particles, RNMR 
is the minimal distance of approach (effective nanoparticle radius), and 𝑀𝑀𝑁𝑁𝑁𝑁𝑇𝑇𝑆𝑆𝑆𝑆𝑇𝑇  is the 
saturation magnetization of the nanoparticles: 





Thus, the relaxivity quadratically increases with respect to nanoparticle radius and 
nanoparticle magnetization[65]. As either the size or the magnetization increases, the 
effective volume at which the particles create magnetic field in-homogeneities increases 
and thus more substantial dephasing of a larger number of water protons occurs. This 
equation is only valid when the following equation is satisfied, where 𝛾𝛾 is the proton 
gyromagnetic ratio, 𝐵𝐵𝐸𝐸𝐸𝐸 is the magnetic field of the contrast agent, and 𝜏𝜏𝐷𝐷 is the diffusion 




𝛾𝛾𝐵𝐵𝐸𝐸𝐸𝐸𝜏𝜏𝐷𝐷 < 1 
This is typically true if the echo time used for measuring the NMR signal is larger 
than 𝜏𝜏𝐷𝐷. As the nanoparticle size grows larger, the amount of time protons spend in its 
vicinity increases to the point where they no longer experience magnetic field in-
homogeneities in the time scale of the measurement. In this case, known as the static 
dephasing region (SDR), r2 is no longer dependent on nanoparticle radius and has reached 
it maximum theoretical value for a fixed concentration and magnetic saturation[66]. At this 
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point, further increases in particle radius actually serve to decrease r2 due to a refocusing 
effect of the spin echo pulse sequences [65]. Based on experimental data and theoretical 
simulations, MRI contract enhancement efficiency can be predicted accurately by simply 
knowing the size and magnetic saturation of the magnetic nanoparticle contrast agents[67].  
2.2.3 Iron Oxide Nanoparticles as MRI Contrast Agents 
Of the relevant T2 MRI contrast agents, superparamagnetic iron oxide nanoparticles 
(IONPs) are the most common[68]. IONPs are magnetic single-domain nanocrystals, 
typically composed of either magnetite (Fe3O4) or maghemite (γ-Fe2O3), which exhibit 
superparamagnetic behavior. Superparamagnetism is a magnetic phenomenon observed at 
the nanoscale; it is a state in which sufficiently small ferromagnetic/ferrimagnetic materials 
exhibit negligible net room-temperature magnetization in the absence of an external 
magnetic field (comparable to paramagnetic materials) while maintaining a high magnetic 
susceptibility (comparable to the bulk ferromagnetic/ferrimagnetic material) (Figure 2-3). 
As such, superparamagnetic particles exhibit strong magnetization in the presence of an 
external field, without remnant magnetization when the field is removed. This behavior 
ensures that colloidal superparamagnetic particles remain stable in solution without 
spontaneous aggregation, while also exhibiting pronounced magnetic effects when 






Figure 2-3: Superparamagnetism. A) Particles in the superparamagnetic regime have 
magnetic moments which rapidly change due to Brownian and Néelian relaxation 
mechanisms, such that there is no net magnetization (M) in the absence of an external field 
(H). B) In the presence of an external field, the magnetic moments of each particle lock in 
place, producing a net magnetization. C) H/M curve showing magnetization only in the 
presence of external fields with no remnant magnetization. 
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 IONPs have generated considerable interest in the nanomedicine field, due to their 
unique magnetic behavior, biocompatibility, and relative ease of synthesis[69]. IONPs 
have seen extensive use as MRI contrast agents[70, 71], but also have been leveraged to 
produce magnetically-guided drug delivery vehicles, hyperthermia agents, vectors for 
bioseparation processes, carriers for gene transfection, and other application[72-78]. In 
particular, the MRI contrast enhancement and drug-delivery capabilities have positioned 
IONPs as dual diagnostic/therapeutic (theranostic) agents[79-81]. 
 The two IONP-based contrast agents approved for clinical use, Ferridex and 
Resovist, have r2 values around 98 mM-1s-1 and 150 mM-1s-1, respectively[70]. There has 
been considerable effort in the field to fabricate magnetic nanoparticles with higher r2 
values that can function as improved contrast agents. One technique to accomplish this has 
been the synthesis of IONPs with larger magnetic moments. Synthetic strategies such as 
thermal decomposition have been used to produce iron oxide nanocrystals with larger sizes, 
more uniform crystallinity, and better control over composition. Contrast agents with r2 
values as high as 760 mM-1s-1 have been created through precise control over iron oxide 
nanocrystal synthesis[82], though IONPs of this quality are challenging to synthesize.  
2.2.3.1 Assembly of Iron Oxide Nanoparticles to Enhance T2 Relaxivity 
Another technique for increasing r2 has been through the controlled clustering of 
individual IONPs, as assemblies of these particles behave as larger magnetic spheres with 
a larger capacity to influence proton relaxation[83, 84]. IONP clustering is traditionally 
accomplished through the use of amphiphilic polymers, which stabilize aggregates of 
hydrocarbon-modified IONPs in a hydrophobic core. A wide variety of block copolymers 
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have been used in this regard, including poly(trimethylammonium ethylacrylate methyl 
sulfate)-b-poly(acrylamide) (PTEA-b-PAM)[85], poly(ethylene imine)-b-poly(ε-
caprolactone)-b-poly(ethylene glycol) (PEI-b-PCL-b-PEG)[86], and poly(ethylene oxide-
b-d,l-lactide) (PEO-b-PL)[87], among others. Other techniques, such as encapsulation in a 
silica matrix[88] and lipoprotein micelles[89] have also been used.  
In addition to their use as MRI contrast agents, IONPs have seen recent 
development as sensing elements for in vitro diagnostic assays or in vivo dynamic 
molecular imaging contrast agents. One technique was developed in 2002 by Ralph 
Weissleder’s lab, in which changes in the T2 signal of water in a sample due to IONP 
interactions were monitored using nuclear magnetic resonance (NMR). Aggregation of the 
particles led to increases in r2 and subsequent decreases in T2 of the sample[86, 90]. This 
type of sensor was termed a magnetic relaxation switch (MRSw). The stimuli-responsive 
behavior was introduced through chemical functionalization of the IONP surface with 
various sensing elements, such as DNA, antibodies, and peptides. Work by Weissleder 
group and others to diversify functionalization with sensing elements have led to sensors 
capable of detecting viruses[91], monitoring enzyme activity[92-96] and calcium 
levels[97, 98], identifying enantiomeric impurities[99], and measuring small-molecule 
analytes such as glucose[100], hormones[101] and antibiotics[102]. As T2 changes can be 
monitored using MRI, similar sensors have also been used for in vivo detection [103, 104].  
Several mechanistic and theoretical studies have been used to elucidate the 
mechanism behind the r2 enhancement following IONP assembly. Theoretical experiments 
utilizing analytical analysis[83] and computational models such as Monte Carlo 
simulations have been used to predict changes in T2 with IONP clusters in a range of sizes 
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[66, 84, 105]. These studies have found that R2 values increase with increasing cluster size, 
which is consistent with the experimental evidence. In these cases, the proposed 
mechanism is based on the increased effective radius of the magnetic particle, leading to 
an increased time that individual water molecules spend within the magnetic field and thus 
increased spin dephasing. In particular, these theoretical studies enable the prediction of 
how precise changes in the nature of the IONP clusters can affect r2 enhancement. Brown 
et al found that R2 scales with an increase in the number of particles following a power law 
relationship, and that the specific scaling factor is dependent on the spatial organization of 
particles within the cluster (fractal dimensions)[66, 105].  The shape of IONP clusters was 
also investigated by Vuong et al, who found that spherical and shell organization strategies 
produced higher R2 enhancements compared to linear assemblies[66]. For linear and 2-
particle IONP assemblies, interparticle distance also plays a role in R2 enhancement, with 
increasing particle spacing leading to decreased R2 enhancement[66, 84]. 
Experimental studies into the mechanisms of r2 enhancement have also been 
conducted. Researchers in the Weissleder group conducted several detailed mechanistic 
studies on their magnetic resonance switch system, using a variety of different IONP core 
constructs (including manganese ferrite particles and iron core-manganese ferrite shell 
particles) with different sizes[106]. They found that R2 enhancement began to level off, 
consistent with moving from the motional averaging regime to the static dephasing regime. 
However, a subsequent decrease in r2 at large cluster sizes for the highest Ms magnetic 
particles pointed to potential decreases in the effective magnetization of the clusters at 
larger sizes. These differences were attributed to the fractal assembly of the particles within 
each cluster.  Similar results were also obtained in work by Poselt et al [86]. Other work 
 
 25 
by Hak et al decoupled particle size from iron concentration by synthesizing oil-emulsion 
droplets of uniform size which would be loaded with varying amounts of IONPs[107]. 
They found that both IONP concentration and droplet size had effects on r2 enhancement, 
and that the quantitative values fell somewhere between that predicted by motion averaging 
regime models and static dephasing regime models. They also hypothesize that water 
molecules trapped in the coating of IONPs could contribute to the r2 enhancement in ways 
not adequately described by the theoretical models used.  Other work has shown that 
reduced magnetic field symmetry contributes to enhanced inhomogeneity and thus 
enhanced r2 was observed using different-sized IONPs included in the same polymer 
emulsion[108]. By varying the molecular weight of the polymer, the researchers were also 
able to establish that increased distance between IONPs led to a small decrease in r2, which 
is consistent with simulations. Relative changes in the number of IONPs in clusters was 
controlled by attaching streptavidin-coated IONPs to biotinylated Zinc-finger proteins 
attached to a linear dsDNA template - attaching ~11 IONPs together led to a small r2 
enhancement of ~10%[109].  
2.3 Molecular Motors and DNA Walkers 
Directed motion at the molecular level plays a critical role in a wide variety of 
biological functions, including intracellular transport and mitosis[110-112]. This 
includes protein molecules which walk along tracks, from the kinesin, dynein, and 
myosin families. These molecular walkers contain “feet” which interact with a track, 
allowing the walker to stay attached to the track while also providing a mechanism for 
motion. There has been considerable interest in developing synthetic motors inspired by 
these biological machines for use as model systems for studying natural processes as 
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well as for technical applications, such as biosensing, molecular computing, etc.[113, 
114]. There are several different characteristics which define molecular walkers. The 
first of these is processivity; that is, the ability of the walker to stay attached to the track 
and to continue motion along this track over multiple cycles. Other parameters include 
directionality (preferential movement towards one side of the track), repetition (repeated 
steps of the motor cycle to enable processive walking), progressive operation (the ability 
of the walker to reset to an original state after each motor cycle), and autonomy (ability 
to continually operate without external interactions as long as fuel is present). While 
molecular machines must have 4 of these 5 characteristics to be classified as a walker, 
autonomy is a characteristic which can be desirable but not necessary. 
2.3.1 Biological Molecular Motors 
The protein molecular walkers move along tracks made of cytoskeletal filaments, 
namely microtubules and actin, and are all ATPases – they convert chemical energy 
generated by the hydrolysis of adenosine triphosphate (ATP) into adenosine diphosphate 
(ADP) into mechanical work. In this case, chemical energy from ATP leads to a 
conformational change in the catalytic motor domain of the protein, driving long range 
(up to 25nm) translation movement[110]. There are over 80 different isoforms within 
the three class of these motor proteins; while these motor protein families share many 
similarities, particularly in regard to the use of ATP as a fuel source, the exact nature of 
their behavior can vary. For example, Myosin-V is a processive motor protein which 
moves along actin filaments through the coordinated motion of 2 "feet", enabling the 
protein to remain bound to the track at all times[115]. In comparison, the related Myosin-
II has only one foot that interacts with actin filaments and thus is not a processive motor 
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(though this behavior is critically important for its role in force generation in muscles) 
[116]. Meanwhile, the kinesin protein KIFIA is a processive motor that only uses one 
foot, maintaining adherence to the track through numerous secondary interactions that 
enable a motion more akin to sliding than walking[117]. One of the most studied motor 
proteins is Kinesin-I, a homodimeric protein with high processivity (~1mm run lengths) 
and directionality enabled by the coordinated out-of-phase movement of two identical 
feet and a slight energetic bias towards forward diffusional "searching" of the next 
binding step[118].  
2.3.2 Mechanisms of Molecular Motors 
The study of natural motor proteins has led to numerous insights into the 
molecular mechanisms for generating both processivity and directionality[114]. In order 
for a motor to be processive, at least one component of the motor must be attached to 
the track at all times. This can be accomplished in several different ways: either through 
the use of two different feet with mutually-exclusive conditions/fuel for unbinding, or 
through the use of an asymmetric track which differentiates the rate at which two 
identical feet bind and unbind (as Kinesin-I). Processive motors with one foot are also 
possible as long as secondary interactions between motor and track keep the motor 
attached during foot unbinding (as KIFIA). More than 2 feet would also allow for highly 
processive movement, though there are no biological motors which act in this manner. 
For directionality to exist, there needs to be some energy state difference between 
subsequent steps in order to bias movement in one particular direction. One method in 
which this can occur is known as the Brownian ratchet method, which requires an energy 
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input (ATP for biological motors, though other energy types are possible), a 
randomization agent (typically thermal fluctuations), and an asymmetric energy 
potential in the direction of motion[119, 120].  There are several different mechanisms 
by which these Brownian ratchets can be constructed. One version is a 'burned-bridge' 
ratchet, in which walker motion consumes footholds it had previously been bound to, 
thus eliminating the possibility for backward motion. In a walker with two different feet, 
directionality can be imparted by incorporating a switchable element into either the 
motor or the track which manipulates the potential energy landscape. Finally, a walker 
with two different feet which includes one irreversible step can create directed motion 
through kinetic control. 
2.3.3 Synthetic Molecular Motors: DNA Walkers 
Of the various types of synthetic motors that have been created, DNA walkers 
are some of the most studied – the precise programmability of DNA makes it an 
excellent material for constructing nanoscale machines. The first realization of a 
synthetic DNA walker came in 2004 in a report by Sherman and Seeman [121]. This 
non-autonomous motor consisted of a triple-crossover DNA tile as a track, with 3 unique 
single-stranded footholds extending from the surface. The DNA walker consisted of two 
dsDNA 'legs' attached to 2 ssDNA 'feet', with the legs attached by flexible ssDNA 
linkers.  The feet were attached to the track foothold via hybridization with sacrificial 
anchor strands, which contain regions complementary to both the foot and the track. 
Addition of a fuel strand led to the removal of the anchoring strand via strand 
displacement, allowing the freed foot to hybridize to the next foothold on the track 
following the addition of the subsequent anchor strand. This simple walker satisfies the 
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four main criteria - it is processive (remains bound to the track through at least one 
anchoring strand at any given time), repetitive, progressive, and exhibits directionality 
through the sequential addition of new anchoring strands. In this instance, the energy 
required for movement comes from the free-energy gain associated with anchor/toe-
hold/fuel strand hybridization. Shin and Pierce reported a very similar system, utilizing 
a single DNA duplex with extended toe-holds as the track and a motor consisting of a 
single dsDNA region along with 2 ssDNA feet[122]. In this instance, the walker moves 
in a 'hand-over-hand' motion where the leading foot switches at each step, in comparison 
to the 'inch-worm' movement of the previous walker. More complex non-autonomous 
motors have also been developed, including a 4-footed triangular DNA walker capable 
of moving across a 2D DNA origami track and picking up/delivering DNA-modified 
gold nanoparticles[123].  
Outside of these non-autonomous DNA walkers, there have been numerous 
reported studies of autonomous DNA walkers using a variety of mechanisms to induce 
movement. Two studies utilized a burnt-bridge brownian ratchet mechanism to facilitate 
walking of a ssDNA motor[124, 125]. In this case, enzymatic activity at motor/foothold 
duplexes provides the energy source for movement. Cleavage of the foothold strand 
frees a ssDNA region of the walker to hybridize to a neighboring foothold via a strand 
displacement mechanism, while the consumption of old footholds facilitates directional 
movement. In one case, a restriction enzyme was used to cleave a recognition site in the 
walker/foot-hold duplex, while the other introduced a DNAzyme directly into the 
walking strand. The first enzyme-free autonomous DNA walker was introduced in 2008, 
involving a single-stranded DNA track consisting of overlapping binding regions 
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(footholds) and a single duplex with two ssDNA feet[126]. Toe-hold mediated binding 
to a meta-stable DNA hairpin H1 in solution leads to the unbinding of a single foot and 
then subsequent freeing of the foot through binding to another hairpin H2. In this 
instance, directionality is enabled due to steric hindrance effects which makes it 
energetically favorable for movement to occur in one direction. A similar enzyme-free 
autonomous walker was subsequently reported involving the movement of a DNA 
walker consisting of 2 different feet which are displaced from the track via signaling 
strand/hairpin interactions[127]. Hybridization of the free foot to a new foothold reveals 
a second signaling strand, allowing the process to repeat. Revealing signaling strands in 
this manner ensures that one foot is bound at any given time (processivity) while 
directionality is ensured due to blocking of previous foot-holds by the hairpin fuel (burnt 
bridge ratchet).   
Autonomous DNA walkers with more than 2 feet have also been constructed, 
including a 'molecular spider' consisting of three DNAzyme legs attached to a 
streptavidin protein core which can move along a 2D DNA origami track[128]. An 
increase in the number of feet enhances the processivity of the motor. Careful design of 
these footholds on the 2D tile enabled the incorporation of turn and stop commands. 
Another study created a molecular walker consisting of up to 6 catalytic legs through 
the use of dimerized streptavidin cores, which could walk through a DNA-coated 
dextran matrix[129].  In an extreme case, Salaita et al developed a rolling DNA motor 
consisting of a DNA-functionalized microparticle moving along an RNA-coated surface 
using RNase H activity to drive movement in a burned-bridge ratchet movement[130]. 
These highly polyvalent motors make thousands of connections to the track at any given 
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time. However, the unique rolling behavior enables high speed movement by limiting 
unproductive sampling interactions. In the other direction, monopodal DNA walkers 
have also been developed, using various designs such as "cleat" domains to ensure 
processivity through constant attachment to the track[131]. 
2.3.3.1 Applications of DNA Walkers 
Beyond their functions as models used to better understand mechanisms of 
directed motion at the molecular scale, DNA walkers have also been developed with 
practical applications in mind, including bioanalysis[132] and molecular computing. 
One-dimensional DNA walkers have been used to detect the presence of target mRNA 
sequences through the transport of cargo molecules to enhance an 
electrochemiluminesence signal[133, 134]. One common theme is the use of DNA 
walkers as a signal-amplification strategy to increase sensitivity - a target molecule 
intitiates movement of a DNA walker which can then catalytically process a large 
number of signal molecules. This strategy is most applicable for walkers which can 
traverse as 2D surface, as this offers a larger pool of signaling molecules to be triggered. 
Walkers which sequentially remove quencher-labeled strands and thus increase 
fluoresence have been developed[135], as well as walkers which remove redox labels 
from an electrode to modify the electochemical signal[136]. Finally, walkers which 
traverse 3D surfaces, typically DNA-modified particles, have been used for the detection 
of both nucleic acids[137, 138] and proteins[139, 140], as well as for cellular imaging 
applications[141, 142]. Beyond sensing applications, DNA walkers have been used 




CHAPTER 3. CONTROL OF IRON OXIDE NANOPARTICLE 
CLUSTERING USING DUAL SOLVENT EXCHANGE 
3.1 Abstract 
Superparamagnetic iron oxide nanoparticles (IONPs) have demonstrated 
considerable promise for magnetic resonance contrast, drug/gene delivery, and 
hyperthermia applications. In recent years, it has been shown that controlling the self-
assembly of SPIOs into larger superstructures can have a significant impact on the 
magnetic properties that dictate the functionality of the particles for biomedical 
applications. In this work, we developed a novel method for controlling the clustering of 
two different SPIO core sizes (8 nm and 15 nm) by varying the amount of amphiphilic 
coating molecule used during the dual-solvent exchange coating process. We show that 
hydrodynamic size and T2 relaxivity can be increased using this method, while the specific 
absorption rate is decreased. These results highlight a new, simple method for triggering 
the self-assembly of SPIOs using commercially available materials.  This approach can be 
used to generate nanoparticles with high relaxivity, promising for contrast-enhanced 
magnetic resonance imaging 
3.2 Introduction 
This section contains text and data that have been reported in a previous publication 
(© 2015 IEEE, reprinted, with permission, from reference [145])  
Superparamagnetic iron oxide nanoparticles (IONPs) have received significant 
attention in the past two decades as potential drug/gene delivery vehicles, MRI contrast 
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agents, and magnetic hyperthermia mediators due to their unique magnetic properties, high 
biocompatibility, and ease of synthesis[69]. Considerable efforts have been made to 
produce high-quality IONPs with improved magnetic properties – notably high T2 
relaxivity for MRI contrast and high specific absorption rate (SAR) for magnetic fluid 
hyperthermia, both important in developing IONPs for a broad range of biomedical 
applications[146]. 
 In addition to improving the quality of synthesis for individual IONPs, recent work 
has demonstrated that controlling the self-assembly of nanoparticles can have a significant 
impact on magnetic properties, including T2 relaxivity and SAR [147, 148]. By controlling 
the size and shape of the final nanoparticle assemblies, T2 relaxivity and SAR can be altered 
to match the intended application. However, the majority of the techniques used to facilitate 
self-assembly utilize non-biocompatible materials, are technically challenging, and/or 
require complicated synthesis of di-block or tri-block copolymers.  
 In this work, we demonstrate a new, simple method to control clustering of IONPs 
using commercially available, biocompatible materials through the dual-solvent exchange 
coating method[149]. This technique involves the gradual increase of the environment 
polarity through a two-step solvent exchange process, which drives the micellization of an 
amphiphilic molecule, typically a phospholipid-poly(ethylene glycol) (PEG) conjugate, 
onto the surface of the hydrocarbon-stabilized iron oxide cores through hydrophobic 
interactions. By controlling the ratio of amphiphilic molecules to iron oxide cores during 
the coating process, we show that clustering of the nanoparticles can be induced, leading 
to colloidally-stable nanoparticles with a range of hydrodynamic diameters. We then 
characterized the T2 relaxivity and SAR of the clustered IONPs, demonstrating the ability 
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to modulate these parameters post-nanoparticle synthesis. This work demonstrates a novel, 
simple method for controlling the self-assembly of individual IONPs into larger 
nanoparticles that show promise as high-sensitivity MRI contrast agents. 
3.3 Materials and Methods 
Iron acetylacetonate (Fe(acac)3, 99%), 1,2-hexadecanediol (technical grade, 90%), 
oleic acid (technical grade, 90%), and oleylamine (technical grade, 70%), toluene 
(>99.9%), chloroform (99%), dimethyl sulfoxide (DMSO 99%) benzyl ether (98%), 
hydrochloric acid, hydroxylamine HCl, sodium hydroxide, ammonium acetate, and 
ferrozine were purchased from Sigma-Aldrich and used as received; 1,2- distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)- 5000] (DSPE-PEG 
5000) was purchased from Avanti Polar Lipids.  
3.3.1.1 Iron oxide nanoparticle synthesis 
Iron oxide nanoparticle cores of 8 nm diameter were synthesized by an adapted 
published procedure[150]. Iron acetylacetonate (6 mmol), 1,2-hexadecanediol (30 mmol), 
oleic acid (18 mmol), and oleylamine (18 mmol) were mixed in benzyl ether (60 ml) in a 
500 ml flask under magnetic stirring. After 40 minutes of incubation under vacuum to 
remove excess oxygen, the solution was raised to 120°C and left for 40 minutes to remove 
excess water vapor. Then the vacuum was removed and replaced by nitrogen flow, and the 
temperature was raised to 200°C and held for 2 hours before ramping to 300°C and holding 
for 1 hour. The mixture was then allowed to cool to room temperature and was purified via 
three repeated rounds of centrifugation using ethanol (240 ml) induced precipitation, 
followed my resuspension in toluene. 15 nm particles were obtained using an iterated seed-
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mediated growth process[150]. Briefly, iron oxide nanoparticle seeds are mixed with an 
amount of iron acetylacetonate based on the necessary mass to increase diameter of iron 
oxide cores by ~2 nm. Oleic acid and oleylamine are added at a 3:1 molar ratio to the iron 
acetylacetonate amount and 1,2-hexadecanediol is added at a 5:1 molar ratio to the iron 
acetylacetonate. Benzyl ether is then added to obtain a final iron acetylacetonate 
concentration of 20 mg/ml. The heating and purification steps were repeated exactly as 
before for the synthesis of the original seeds. 
3.3.1.2 IONP- DSPE-PEG Coating 
 To render the as-synthesized iron oxide cores water soluble, the dual solvent 
exchange coating method was utilized. Briefly, 200 µL of iron oxide cores (5 mg Fe/mL 
in toluene) was added to 800 uL of chloroform with differing amounts of 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-
PEG), ranging from 0.5 mg (0.5:1 w/w DSPE-PEG:Fe coating ratio) to 4 mg (4:1 coating 
ratio).  4 mL of DMSO was added dropwise to the solution over 30 minutes in an argon 
environment. Chloroform and toluene were then removed under vacuum, followed by 
addition of 16 mL of de-ionized water over 30 minutes using a syringe pump. The mixture 
was substituted with fresh water using three rounds of centrifugation in centrifugal filter 
tubes (Vivaspin 20, 100kDa MWCO). Finally, empty micelles were removed by three 





3.3.1.3 Iron Concentration Measurements 
Iron concentrations were measured using the colorimetric ferrozine assay[151]. For 
water-soluble coated IONPs, 50 µl of sample was mixed with 50 µl of 12 M HCl and 
incubated at room temperature for 30 minutes. For IONPs suspended in toluene, 10µL of 
IONP sample was added to 50uL of 12 M HCl and incubated at room temperature for 30 
minutes with occasional vortexing, then 10uL of the aqueous phase was removed and 
added to 50 µL de-ionized water and 40 µL 12 M HCl. 240 µl of 2 M NaOH, 50 µl of 4 M 
ammonium acetate, 110 µl 5% hydroxylamine HCl, and 500 µl water were then added 
sequentially to the mixture in that order. After 30 minutes of incubation, 50 µl of the 
solution were mixed with 0.02% ferrozine solution in a 384 well plate. Light absorption 
was read at 562 nm with 810 nm as the reference wavelength using a microplate reader. 
The absorption was compared to a molecular iron standard to determine the concentration.  
3.3.1.4 Characterization 
 Transmission electron microscopy (TEM) was used to determine the size and shape 
of the iron oxide cores after synthesis. Briefly, 5 µL of as-synthesized cores in toluene (~ 
40 µg Fe/mL) were drop-cast onto carbon coated TEM grids. Images were recorded using 
a HT7500 microscope (Hitachi) operating at 75 kV attached to a CCD camera. 
 Dynamic light scattering (DLS) was used to investigate the hydrodynamic 
diameters of the coated iron oxide nanoparticles. Samples were diluted to 100 µg Fe/mL 
in de-ionized water and filtered using a 0.2µm syringe filter to remove dust particles. 
Measurements were taken at 25°C using a DynaPro Nanostar DLS instrument (Wyatt). The 
intensity weighted distribution was reported. 
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 The effect of aggregation on MR contrast was measured using a 0.47 T Minispec 
Analyzer MQ20 (Bruker). The transverse relaxation times of IONPs (concentrations from 
1 µg Fe/mL to 10 µg Fe/mL) were recorded at 40°C using the Hahn spin-echo method. T2 
relaxivity (r2) was calculated by plotting 1/T2 against the molar concentration of iron and 
calculating the slope using linear regression. 
 Magnetic fluid hyperthermia heating efficiency was analyzed by measuring the 
temperature rise when samples were exposed to an alternating magnetic field (3355 kHz, 
23.77 kA/m) generated by a 7.5-turn, 2.54 cm inner diameter inductor coil. A 1 mL aqueous 
suspension of IONPs (400 µg/mL) was placed inside the coil with polystyrene insulation, 
and the temperature was measured in real time using a fiber optic temperature probe. The 
slope of the linear region of the temperature vs. time plot was calculated using linear 
regression and normalized to a water sample. The specific absorption rate (SAR) was 









where Cp is the specific heat of water, mH2O is the mass of water, ΔT/t is the normalized 
slope of the temperature vs. time plot, and mFe is the mass of iron. 
 All presented values represent 3 independent measurements of single samples. 




3.4 Results and Discussion 
IONP cores were synthesized using the thermal decomposition method in benzyl 
ether with Fe(acac)3 as the metal precursor. The synthesized particles were monodisperse 
with diameters of 8.2 ± 1.6 nm and 15.1 ± 2.2 nm as measured by TEM (Figure 3-1). The 
particles displayed superparamagnetic properties, with magnetic saturation values of 88.4 
and 89.6 emu/g for 8 nm and 15 nm IONPs, respectively, as measured using a SQUID 
magnetometer.  
 
Figure 3-1 : Iron Oxide Nanoparticle Characterization. Representative TEM images of 
A) 8 nm and B) 15 nm iron oxide cores. Scale bar – 100 nm 
We sought to investigate if the self-assembly of IONPs into clusters could be driven 
by modifying the dual-solvent exchange coating technique. The dual-solvent exchange 
process works by altering the surface energy of the iron oxide cores through changes in the 
polarity of the environment. This increases the strength of hydrophobic interactions 
between the hydrocarbon ligands on the nanoparticle surface and the phospholipid block 
of DSPE-PEG, driving self-assembly into the final core-shell structure in a process 
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analogous to the formation of micelles. We had previously observed that larger coating 
ratios (defined as the mass ratio of DSPE-PEG to iron in the coating reaction) were 
necessary to stabilize smaller iron oxide cores. This is presumably due to their higher total 
surface area per mass of iron (i.e. higher surface area to volume ratio) - an increased amount 
of DSPE-PEG was needed to stabilize the increased hydrophobic surface area. This 
inspired us to attempt to shift the equilibrium of the system by purposefully using lower 
coating ratios, such that DSPE-PEG would no longer be in sufficient quantity to stabilize 
the entire surface area of cores as single entities. We hypothesized this would force the 
nanoparticles to cluster within the DSPE-PEG shell in an effort to minimize their surface 
energy and reduce the total surface area to be stabilized by DSPE-PEG. 
 Two different sizes of iron oxide cores (8 nm and 15 nm) were coated at different 
DSPE-PEG:Fe coating ratios (from 0.5:1 to 4:1 w/w), and the resulting nanoparticles were 
analyzed using dynamic light scattering. We found that lower coating ratios resulted in 
larger hydrodynamic diameters, indicative of core clustering induced by the coating 
process (Figure 3-2). We only show results for two coating ratios which produced singly-
dispersed cores (4:1 and 2:1 for 8 nm cores, 2:1 and 1:1 for 15 nm cores), and two coating 
ratios which produced clustered systems (1:1 and 0.75:1 for 8 nm cores, 0.75:1 and 0.5:1 
for 15 nm cores). When coating ratios were normalized based on iron oxide core surface 
area, it can be seen that both iron oxide cores begin to cluster when the coating ratio is less 






Figure 3-2: Size Distribution of Iron Oxide Nanoparticle Clusters. Intensity-weighted 
size distributions obtained via DLS of A) 8 nm IONP and B) 15 nm IONP coated with 
different mass ratios of coating particle (DSPE-PEG:Iron). C) Average diameter as a 





 This value compares favorably with Tong et al[149], who calculated that 6.5 nm 
iron oxide cores coated at a 1:1 DSPE-PEG:Fe ratio had a surface coverage of ~1.6 DSPE-
PEG molecules per nm2 for singly-dispersed nanoparticles. The formation of empty 
micelles during coating is likely a competing process, which reduces the nominal amount 
of DSPE-PEG available for coating the iron oxide cores, such that an initial loading ratio 
of ~2 DSPE-PEG molecules per nm2 is unlikely to be the final density of DSPE-PEG on 
the nanoparticle surface. It appears that if the amount of DSPE-PEG available for coating 
is insufficient to reach that particular surface coverage, the particles cluster together to 
reduce their exposed surface area. The fewer DSPE-PEG molecules present initially, the 
greater the extent of clustering when the solution reaches equilibrium. 
Next, we sought to examine how IONP clusters created with our technique could 
be used as MRI contrast agents. Iron oxide nanoparticles generate MR contrast by 
shortening the transverse relaxation of water protons in their vicinity. This can be 
quantified by the relaxivity r2 (defined as the decrease in the characteristic relaxation time 
T2 per concentration of iron). As expected, 15 nm cores showed higher relaxivity values 
compared to 8 nm cores, consistent with previous results[152]. For 8 nm cores, singly-
dispersed cores (4:1 and 2:1 coating ratios) showed similar r2 values (94 and 89 mM-1s-1, 
respectively), while the clusters showed higher r2 values up to 165 mM-1s-1 (0.75:1 coating 
ratio) (Figure 3-3). The same trend was observed for 15 nm cores (Fig. 3B), with r2 values 
ranging from 269 mM-1s-1 for singly-dispersed cores (2:1 and 1:1 coating ratio), up to 634 





Figure 3-3: T2 Relaxivity of Iron Oxide Nanoparticle Clusters. Calculated T2 relaxivity 
for (a) 8 nm and (b) 15 nm IONP cores coated with different DSPE-PEG:Fe ratios (mean 
± s.d., n = 3). 
 
 Outer sphere theory predicts that r2 values increase as particle size increases, known 
as the motional averaging regime (MAR), due to an increase in the local magnetic field 
homogeneities that lead to dephasing of water protons in the vicinity of the particles.  
Monte-Carlo simulations of magnetic nanoparticle clusters by Matsumoto et al. 
demonstrate increased R2 with increasing aggregate size, as these clustered particles are 
believed to behave magnetically as single large spheres[84]. The increase in R2 due to 
nanoparticle clustering has been achieved experimentally by other groups, but the 
techniques utilized to drive self-assembly involve the use of di-block or tri-block 
copolymers synthesized in-house[85-87]. This increases the complexity of the method, 
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decreasing the accessibility for other labs and increasing potential regulatory hurdles. The 
technique presented here uses commercially available and FDA-approved DSPE-PEG, 
which simplifies the overall process. Furthermore, the R2 value of 634 mM-1s-1 for the 
largest cluster of 15 nm IONP cores is among the highest ever reported.  
Finally, we investigated the potential of the clustered IONPs to act as mediators for 
magnetic fluid hyperthermia. When placed in an alternating magnetic field, 
superparamagnetic nanoparticles experience relaxation losses (either Néelian or Brownian) 
which dissipate heat into the surrounding environment[153]. This heat generation can be 
quantified by the specific absorption rate (SAR), which describes the power output per 
mass of particles. The SAR was calculated by measuring the temperature increase of an 
aqueous solution of particles over time when exposed to AMF (355 kHz, 23.77 kA/m) (Fig. 
4). As with T2 relaxivity, we found that 15 nm cores showed higher SAR values compared 
to 8 nm cores, consistent with previous work[154].  
 For 8 nm cores, SAR values decreased with increasing cluster size from 147 W/g 
to 67 W/g for coating ratios of 4:1 and 0.75:1, respectively (Figure 3-4). 15 nm cores 
showed a similar trend, with SAR values decreasing from 616 W/g to 133 W/g for coating 
ratios of 2:1 and 0.5:1, respectively. While there is still debate about the effect IONP 
clustering has on SAR, the results here are consistent with the majority of those in the 
literature using similar systems[155, 156]. Both experimental and theoretical work have 
demonstrated that increased dipole-dipole interactions, which is likely to occur in clustered 
nanoparticle systems, lead to decreased heat output[157, 158]. Urtizberea et al found that 
increasing nanoparticle concentration (and thus increasing dipole-dipole interactions) 
decreased Néelian relaxation time and increased initial susceptibility, leading to a decrease 
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in SAR[159]. While more work is needed to fully elucidate the exact cause of SAR 
reduction in our present system, it appears that these clustered IONPs provide no clear 
benefit over singly-dispersed cores for hyperthermia applications. 
 
Figure 3-4: Heat Generation from Iron Oxide Nanoparticle Clusters. Calculated SARs 
for (a) 8 nm and (b) 15 nm iron oxide cores coated with different DSPE-PEG:Fe ratios 





CHAPTER 4. PRECISE CONTROL OVER SPATIAL 
ORGANIZATION AND T2 RELAXIVITY OF IRON OXIDE 
NANOPARTICLES USING DNA ORIGAMI 
4.1 Abstract 
The assembly of iron oxide nanoparticles into clusters is a promising avenue for the 
development of the highly efficient contrast agents for molecular imaging applications 
using MRI. Current techniques for inducing clustering are relatively crude, producing 
heterogeneous populations of primarily spherical arrangements with minimal control over 
the spatial organization of individual particles. In contrast, structural DNA nanotechnology 
has emerged as a promising technology for the organization of materials into arbitrary, 
prescribed shapes at the nanoscale. We have developed a DNA origami nanorod that is 
capable of precisely arranging DNA-coated iron oxide nanoparticles into prescribed 
patterns and use this system to investigate how parameters such as particle number and 
inter-particle spacing effect enhancement in MRI contrast generation. We demonstrate 
independent control over the number and spacing of iron oxide nanoparticles using the 
underlying DNA nanostructure as a scaffold. Furthermore, we find that discrete variations 
in the number of particles lead to significant increases in T2 relaxivity, with a maximal 
enhancement of 140%. In contrast, variations in particle spacing between 40 and 100 nm 
appears to have little to no effect. This system is a promising platform to interrogate the 
effects of iron oxide nanoparticle self-assembly on MRI contrast, facilitating the creation 




Magnetic resonance imaging (MRI) has emerged as a staple of modern diagnostic 
medicine with a wide variety of uses. However, there are some instances in which native 
contrast between regions of the body with similar chemical/magnetic properties makes it 
difficult to identify and diagnose a variety of pathologies. In these instances, an exogenous 
contrast agent can be used to artificially alter the MRI signal and thus enable the 
identification of contrast agent biodistribution and its interactions with native tissues. 
Superparamagnetic iron oxide nanoparticles (IONPs) are one class of contrast agent which 
has demonstrated clinical success and generated considerable pre-clinical research interest 
as molecular imaging agents. One major focus of these research efforts is to synthesize 
more efficient IONP-based contrast agents, which can generate stronger MRI signals at 
lower delivered doses. One particularly appealing option is the assembly of individual 
particles into larger clusters, which has been demonstrated to produce significant 
enhancements in T2 relaxation. The majority of techniques used to induce this self-
assembly leverage hydrophobic-hydrophilic interactions between hydrophobic IONPs and 
amphiphilic polymers to cluster IONPs inside a polymer shell[85-87, 145]. These 
techniques are limited to producing heterogeneous populations of isotropic spherical 
clusters with minimal control over the spatial organization of particles within the 
assemblies. Other studies have demonstrated the use of anisotropic scaffolds such as 
bacteriophages[160] and DNA[109] to direct the assembly of IONPs, but in-depth studies 
using these systems is still limited. Theoretical simulations of this clustering-induced T2 
enhancement have been used to predict how fine changes cluster organization alter MRI 
contrast, but the lack of experimental control over these parameters has hindered model 
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validation [66, 83, 84, 105]. A new technology is needed to facilitate control over the 
spatial organization of IONPs in order to better understand cluster-induced T2-contrast 
enhancement and engineer the next generation of iron-based MRI contrast agents. Over the 
past decade, structural DNA nanotechnology has emerged as one of the premier platforms 
for the precise organization of matter at the nanoscale. DNA nanostructures have been used 
for the organization of a diverse range of materials, including gold nanoparticles, quantum 
dots, fluorescent dyes, and proteins[1]. However, the use of this technology to direct the 
assembly of IONPs has been extremely limited, with only one previously published study 
demonstrating minimal control over spatial organization and no functional effects[161]. In 
this work, we demonstrate the ability to precisely control the spacing and number of DNA-
modified IONPs using a custom-designed 130 nm DNA origami rod, allowing us to 
investigate how these parameters affect T2 relaxivity. This work represents a novel method 
for controlling the clustering of IONPs with high precision, opening up the possibility for 
the precise engineering of MRI contrast agents that can be used for sensitive molecular 
imaging applications. 
4.3 Materials and Methods 
4.3.1.1 Materials 
All short synthetic oligonucleotides were purchased from IDT, using desalting 
purification where available (and HPLC-purification for modified strands where 
necessary). All strands were used without further purification, unless otherwise noted. M13 
bacteriophage and E. Coli were obtained from collaborators. OligoTex beads were 
purchased from Qiagen. Freeze’N’Squeeze Columns were purchased from BioRad. NAP-
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5 columns were purchased from GE Healthcare. Dibenzocyclooctyne-ester (either N-
hydroxysuccinimide or sulfo-tetrafluorophenol) were purchased from Click Chemistry 
Tools. 15 nm hydrophobic IONPs and 10 nm streptavidin-modified IONPs were purchased 
from Ocean Nanotech.  Poly(maleic anhydride-octadecene)-azide (PMAO-N3) and 10 nm 
DNA-coated IONPs were provided by collaborators (Chuan Zhang). All other chemicals 
were purchased from Sigma Aldrich or Fisher Scientific and used as received. 
4.3.1.2 Scaffold Preparation 
The p7560 scaffold was prepared following a published protocol[162]. All 
solutions and tubes were autoclaved prior to use. K91endA E. Coli cells were grown 
overnight in LB media in a shaking incubator (37C, 280 rpm) until proper density was 
reached, as determined by absorbance at 600nm. An aliquot of the LB/bacteria solution 
was then transferred to 2xYT media and allowed to grow for an additional 1.5 hours (37C, 
280rpm) until proper density was reached (~0.5OD). 1mL of 1M magnesium chloride 
(MgCl2) was added, followed by the addition of p7560 bacteriophage diluted 8x in 10mM 
Tris buffer. Bacteria were allowed to grow in the incubator for another 2 hours, and then 
the growth media was transferred to 500mL centrifuge flasks. The solution was centrifuged 
(8,000xg, 4°C, 15 minutes) to pellet bacteria and the supernatant was removed. 400mL of 
supernatant was added to 12 grams sodium chloride (NaCl, 3% w/v final concentration) 
and 16 grams of poly(ethylene-glycol) with 8000 molecular weight (PEG-8000, 4% w/v 
final concentration) and placed in an ice bath for 10 minutes. Bottles were centrifuged 
again with same conditions to precipitate phage. The supernatant was decanted and the 
pelleted phage was resuspended in 4mL 10mM Tris buffer. Next, 8mL of 0.2M sodium 
hydroxide (NaOH)/1% SDS solution was added and incubated for 2 minutes, followed by 
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the addition of 6mL 3M potassium acetate, pH 5.5 and incubated for 20 minutes on ice. 
The tubes were centrifuged and the supernatant containing the p7560 scaffold was 
removed. EtOH precipitation was then used to concentrate DNA and remove excess salt, 
and DNA concentration was normalized to 200nM with dilution in ultra-pure water. 
4.3.1.3 DNA Origami Design and Synthesis 
DNA origami structures were designed using the caDNAno software[14] on a 
square lattice with a 4x4 double-helix grid (16 helix bundle, 16HB). To synthesize the 
structures, staples were mixed with p7560 DNA scaffold (10-30 nM) in 10-fold molar 
excess in aqueous buffer (5 mM Tris base, 1 mM EDTA, and 10mM MgCl2 ) with a total 
volume of 50 μL. The solution was annealed in a thermocycler over 18 hours, following 
the protocol: 85°C for 10 minutes to denature strands, then 60 to 24 °C, at 30 min/°C. 
Additional details about designing and synthesizing DNA origami structures can be found 
elsewhere [9, 163].  
4.3.1.4 Agarose Gel Electrophoresis and 16HB Purification 
Crude DNA origami/staple mixtures were run on native agarose gel electrophoresis 
with varying percentages (typically 1.5% for analytical gel and 0.67% for high yield 
purification gel) for 1-2 hours (gel prepared in 0.5 × TBE buffer - 45 mM Tris, 45 mM 
Boric acid, 1 mM EDTA, 10 mM MgCl2 and 0.005% (v/v) EtBr) at 50-60V, depending on 
the size of gel box. Then, the target bands were excised and placed into a Freeze ’N Squeeze 
column. The gel pieces were crushed into fine pieces by a microtube pestle and the column 
was then centrifuged at 7000 rcf for 5 minutes. Samples that were eluted through the 
column were collected for subsequent experiments. The concentration of 16HB samples 
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was estimated by measuring the weight-concentration of dsDNA using a NanoDrop 
spectrophotometer at 260nm and dividing by the approximate molecular weight (4.6MDa). 
4.3.1.5 PEG Precipitation Purification 
High yield recovery of 16HB was obtained using a PEG precipitation method, as 
described elsewhere[163]. Briefly, crude DNA origami mixtures obtained directly after 
annealing were adjusted to a final volume of 200uL and a final concentration of 20mM 
MgCl2 using 1xFoB (5mM Tris, 1mM EDTA, 5mM NaCl) and 100mM MgCl2. 0.7uL of 
a .01% EtBr was added to the solution, along with 200uL of the precipitation solution (15% 
w/v PEG-8000, 5mM Tris, 1mM EDTA. 505mM NaCl). The mixture was centrifuged 
(16,000xg, 4°C, 25 minutes), and the supernatant was decanted under UV-irradiation to 
assist in pellet identification. The pellet was resuspended to 200uL 1xFoB+20mM MgCl2 
and then precipitation process was repeated again. The final pellet was resuspended in 
1xFoB+10mM MgCl2 for further use.  
4.3.1.6 Transmission Electron Microscopy (TEM) Sample Preparation 
3 to 8 μL of samples were deposited onto glow-discharged, carbon-coated copper 
TEM grids for 30 seconds – 5 minutes, depending on approximate 16HB concentration. 
Residual solution was wicked away using filter paper and grids were then stained for 30 
seconds using a 1% aqueous uranyl formate solution containing 25 mM NaOH. Imaging 





4.3.1.7 IONP Concentration Measurements 
Iron concentrations were measured using the colorimetric ferrozine assay. 50 µl 
IONP solution (approximate concentration ~40 µg/mL) was mixed with 50 µl of 12 M HCl 
and incubated at room temperature for 30 minutes. 240 µl of 2 M NaOH, 50 µl of 4 M 
ammonium acetate, 110 µl 5% hydroxylamine HCl, and 500 µl water were then added 
sequentially to the mixture in that order. A low volume protocol for use with small 
quantities of samples was also developed, using 1/5th volumes (10uL sample, 10uL 12M 
HCl, 48uL 2M NaOH, 10uL 4M ammonium acetate, 22uL hydroxylamine HCl). After 1 
hour of incubation, 50 µl of the solution were mixed with 0.02% ferrozine solution in a 
384 well plate and left for 1 hour on mixer. Light absorption was read at 562 nm with 810 
nm as the reference wavelength using a microplate reader. The absorption was compared 
to a molecular iron standard to determine the concentration. Molar IONP concentrations 
were calculated from iron weight concentrations by calculating the mass of a single particle 
assuming perfect spherical geometry, an Fe3O4 density of 5.15 g/cm3, and a Fe3O4 weight 
concentration 38% higher than Fe weight concentration. For example, a 100ug/mL Fe 
concentration would give 25nM for 15nm IONP cores and 85nM for 10nm IONP cores. 
4.3.1.8 DNA-IONP Synthesis – IONP Coating 
IONP were coated with PMAO-N3 using a previously published protocol[164]. 
Briefly, a 20mL scintillation flask and stir bar were washed with deionized water, dried 
overnight in an oven at 90°C, and then washed with anhydrous chloroform stabilized with 
amylene (Note: VERY important to use amylene-stabilized chloroform, rather than 
ethanol-stabilized chloroform). Anhydrous amylene-stabilized chloroform and IONPs 
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(25mg/mL Fe, 6.3µM IONP) were mixed together in the vial to a final concentration of 
50nM IONP in 5mL of chloroform. To this mixture, 200mM (monomer concentration) 
PMAO-N3 was added dropwise into the mixture under stirring until the ratio of polymer 
monomer units to IONP surface area was 300:1 (corresponding to ~210,000 molar excess 
for 15nm IONPs). This solution was allowed to incubate at room temperature on a stir plate 
for 2 hours. The tube was then placed in a ~55°C water bath for 2 minutes with gentle 
mixing, and then allowed to cool to room temperature over 15 minutes. Chloroform was 
removed using a rotary evaporator, and the thin IONP film was hydrated in 2 mL of 75mM 
sodium borate, pH 9 solution via sonication for 1 hour. The resuspended IONP were 
filtered using a 0.2µm syringe filter and then purified using ultracentrifugation on a sucrose 
gradient (20-50% sucrose, 100,000xg, 2.5 hours, 4°C). The band containing the well-
dispersed coated IONPs was removed using a syringe, and excess sucrose was eliminated 
using 3 rounds of washing in a VivaSpin (GE Healthcare) tube with 100 kDa molecular 
weight cut-off filter using deionized water. Coated particles were then stored at room 
temperature in deionized water until further use. 
4.3.1.9 DNA-IONP Synthesis – DNA-DBCO Synthesis 
In a typical synthesis, 50uL 1mM Amine-modified ssDNA was mixed with 50uL 
30mM DBCO-STP Ester, 50uL 10x PBS, 50uL 1M sodium bicarbonate (prepared fresh), 
and 300uL deionized water, to give a final solution of 500uL, 100µM DNA, 30-fold excess 
DBCO-STP Ester, 1x PBS, 100mM sodium bicarbonate. The tube was covered in foil and 
placed on mixer and left at room temperature overnight. For purification, the mixture was 
run through 3 rounds of ethyl acetate extraction, in which 1mL of ethyl acetate was added, 
the mixture was vortexed for 1 min, centrifuged at low speed, and then the ethyl acetate 
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was removed (Note: This part of the protocol was based on using DBCO-NHS esters which 
are more hydrophobic, and it is not clear if the ethyl acetate extraction is really need to 
remove excess DBCO-STP esters). 1mL of ethanol was added, and the mixture was stored 
at -20C for ~30 minutes, and then centrifuged (16,000xg, 4C, 30 minutes). The supernatant 
was decanted, the pellet dried and then resuspended in 500uL H2O, and then the mixture 
was desalted using a NAP-5 desalting column. The flow through was collected and the 
water removed using a speed-vac, followed by resuspension of the dried DNA in H2O. The 
use of DBCO-NHS esters was also used and worked well – 50mM DBCO in DMSO was 
used, and the 300uL of water was replaced with 250uL DMSO, 50uL water (for 60% 
DMSO final volume). In this case, a precipitate formed during overnight incubation, 
though this did not appear to impact the quality of the final product. Finally, HPLC could 
also be used to purify the DBCO-DNA and is theoretically better because it removes 
unreacted amine-DNA. However, there was no significant difference in either method 
when testing IONP conjugation, so ethyl acetate extraction and desalting was primarily 
used due to the fact that it is simpler. 
4.3.1.10 DNA-IONP Synthesis – DNA Conjugation 
DNA strands were conjugated to PMAO-N3-coated IONPs using a copper-free 
click chemistry reaction, based on a previously published protocol (Zhang 2013). DBCO-
modified ssDNA was mixed with PMAO-coated IONPs with a final ratio of 1 DNA/nm2 
IONP surface area (for 15nm IONPs, this corresponded to 700x molar excess). Reactions 
were typically run in 100uL deionized water with 50nM IONPs – larger volumes led to 
issues with reaction efficiency. The DNA/IONP mixture was allowed to incubate overnight 
at room temperature on mixer. A salt-aging protocol was then used to increase density of 
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DNA on the IONP surface - titrated additions of 5M NaCl were added to the DNA/IONP 
solution over 8 hours, with new NaCl additions every hour.  Volumes of NaCl were added 
to raise concentration to 50mM with first addition, 100mM for second addition, and then 
in 100mM steps up to 700mM after 8 hours.  The final mixture was then left overnight at 
room temperature on mixer, followed by purification using 3 rounds of centrifugation 
(18,200xg, 1 hour) and resuspension in 1xFoB.  
4.3.1.11 DNA-IONP Characterization 
DNA-IONPs were characterized using both dynamic light scattering (DLS) and 
agarose gel electrophoresis. 50µL of a DNA-IONP solution (~5nM IONP) was added to a 
glass-bottom 384 micro-well plate and light scattering was measured using a DynaPro III 
plate reader (Wyatt Technologies). The hydrodynamic size and polydispersity index were 
calculated using cumulants analysis, while the regularization size distribution results were 
reported as the intensity-weighted distribution. For agarose gel electrophoresis, DNA-
IONPs were loaded into a 1% agarose gel made with 1xTBE buffer and ran for 30 minutes. 
Ethidium bromide staining and UV illumination was used to visualize excess PMAO-N3 
polymer present in solution. 
4.3.1.12 16HB-IONP Binding 
Many different conditions were tested for optimizing binding of DNA-IONP to 
16HB, and a general method is presented here. A 5-fold excess of IONP relative to the 
number of IONP binding sites was added to 1 - 2.5nM of 16HB in a final volume of 20-
200uL. For example, for a 1nM solution of 16HB containing 3 binding sites would have a 
final DNA-IONP concentration of 15nM. The reaction was run in 1xFoB10 (5mM Tris, 
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1mM EDTA, 5mM NaCl, 10mM MgCl2) and left to incubate for a specific time (15 
minutes to overnight) at room temperature on a shaker. Agarose gel electrophoresis was 
used to monitor binding efficacy, and bands were excised and purified for TEM analysis. 
Binding yields were calculated by counting each 16HB in the field of view and binning 
based on the number of bound IONPs. 
4.3.1.13 16HB-IONP Bead Purification 
While the exact volumes and concentrations were varied based on the needs of the 
experiment, a general method for purification of 16HB-IONP from excess IONP is 
presented here. 4uL of Oligotex beads were washed via 1 round of centrifugation (7,000xg, 
2 min) in 400uL of FoB10 (5mM Tris, 1mM EDTA, 5mM NaCl, 10mM MgCl2) containing 
0.01% Pluronic F-127 in a tube that had been blocked with a 5% Pluronic solution.  A 
16HB-IONP mixture (typically 200uL at around 1-2nM 16HB) was added to a tube 
containing the washed beads, and the mixture was left at room temperature for 3 hours on 
a rotary mixer. In general, 1uL of beads was used for every ~0.1pmol of 16HB (e.g. 4uL 
of beads for a 200uL, 1.5nM solution). After the 3-hour incubation step, the mixture was 
centrifuged (7,000xg, 2 min) and the supernatant was collected/discarded. The pellet was 
resuspended in 200uL of FoB10+F-127 and the process was repeated 2x more, for a total 
of 3 centrifugation steps. The use of buffer containing Pluronic was critical to prevent beads 
from adhering to the plastic tube, leading to a substantial loss of product. 4uL of release 
strand (containing a 25 polyA sequence and sequence complementary to 16HB connector 
toehold) was added to the bead/bound 16HB mixture and the tubes were left to incubate at 
37°C in a rotary mixer, typically for ~16 hours. The amount of release mix added was not 
particularly important as long as it was in a large enough excess. In general, an equivolume 
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amount of 100uM release strand mix was added as Oligotex beads. After overnight 
incubation, the mixture was centrifuged again, and the release product was collected from 
the supernatant. Secondary centrifugation steps were occasionally needed to remove any 
excess beads that were left in supernatant. The quality of the release products was analyzed 
via agarose gel electrophoresis and TEM. Yield of release was calculated using ImagePro 
software by comparing relative band intensity of release and supernatant steps to a control 
impure sample. 
4.3.1.14 T2 Measurements 
After collecting 16HB-IONP following bead purification, the samples were diluted 
1:2 and 1:4 times in 1xFoB10+.01% F-127 to a final volume of 600uL each. Samples were 
then transferred to a 10mm NMR tube and T2 was measured using a Resonance Maran 
Ultra NMR. T2 values were extracted by fitting an exponential decay to data obtained from 
a standard CPMG pulse sequence. The measurement parameters include: 0.55 T, 30°C, 
Number of Echoes: 1024, Time delay between echoes: 1ms, pulse length - 3µs, receiver 
delay: 10s. The T2 values at 3 different concentrations were obtained, and a linear fit was 
used to calculate r2. Samples were then heated at 85°C for 10 minutes to denature the 16HB 
support, left to cool to room temperature for 1 hour, and then T2 values were measured 
again and r2 was calculated. Data was presented as percent change relative to heating 
% 𝐶𝐶ℎ𝑎𝑎𝑎𝑎𝑔𝑔𝑒𝑒 𝑟𝑟2 = 100 × 
𝑟𝑟2 𝑏𝑏𝐹𝐹𝑏𝑏𝑏𝑏𝑏𝑏𝐹𝐹 ℎ𝐹𝐹𝑒𝑒𝑡𝑡
𝑟𝑟2 𝑒𝑒𝑏𝑏𝑡𝑡𝐹𝐹𝑏𝑏 ℎ𝐹𝐹𝑒𝑒𝑡𝑡 
 
For dynamic T2 Measurements, T2 values for 2 identical samples were measured. 1µL 
of 6.25µM dimerization strands were added to one tube (600uL) and both samples were 
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left at 35°C on heating block. T2 values for both were measured again at 1 hour, 3 hours, 
and 24 hours. Samples were then denatured as above and T2 was measured again. Values 
are presented as T2 normalized to either initial measurement (t = 0) or to the control sample 
without dimerization strands at each time point. 
4.4 Results 
4.4.1.1 16HB Design and Synthesis 
The DNA origami rod used in this work was designed using caDNAno on a square 
lattice and consisted of 16 double helices bundled together on a 4x4 grid, with each helix 
~396 bp long, or roughly 133 nm. ~20bp long free scaffold loops were included on each 
end to prevent base-stacking interactions, but also served as anchoring points for attaching 
additional strands used for incorporating elements on the ends of the structure. Individual 
staple domains were either 8 or 16nt long (3 or 4 domains per staple) with ~23nt between 
cross overs. Staple break points were designed in a way to produce 36 3’/5’ ends on each 
face of the rectangular prism, arranged in 3 groups of 12. Using this system, additional 
domains could be appended to each of these break points, providing “capture” sequences 
extending from the faces of the 16HB structure that could interface with heteroelements 
labeled with complementary DNA. In this way, there are a maximum of 48 3-strand 
binding sites, with 12 located on each side of the rectangular prism. The caDNAno design 






Figure 4-1: Characterization of 16HB DNA Origami Rod A) Model of 16HB B) AGE 
of 16HB; M - 1kB marker, S - p7560 scaffold C) Negative-stain TEM images of 16HB D) 







The 16HB structure was synthesized using a thermal annealing protocol with a 
mixture of p7560 scaffold strand and excess staple strands and was then characterized using 
agarose gel electrophoresis and transmission electron microscopy (Figure 4-1).  The 16HB 
assembles with high yield and migrates faster than the free scaffold on 1.5% agarose gels 
due to its compact geometric form. There does appear to be some minor 
dimerization/oligomerization as observed by a slower moving band. However, these 
byproducts do not appear to interfere with downstream applications. Negative-stain TEM 
imaging of the structures reveals well-formed rectangular prisms, with high magnification 
images showing the 4 parallel helices stacked together. Analysis of these structures gives 
an average length of 127 ± 8 nm, which matches well with the designed geometry (133 
nm). While DNA origami structures are ideally highly monodisperse, the small variability 
in lengths observed here could be due to several factors: broken or damaged structures in 
which some of the length is lost can contribute to shorter 16HBs, while staining 
phenomenon which accentuate the free scaffold loops or human error during measurement 
could contribute to structures measured as larger than 135 nm.  
In order to optimize assembly of the 16HB, we annealed structures in buffers 
containing variable amounts of MgCl2 (8-18mM). Based on agarose gel mobility, the 16HB 
forms with high yield between 8 and 14mM, with assembly in 18mM magnesium leading 
to a decreased yield due to the appearance of large aggregated byproducts (data not shown). 
In order to further optimize assembly conditions, we varied a number of different 
parameters (magnesium concentration, assembly time, annealing temperature, and p7560 
scaffold source) and analyzed the resulting 16HB using TEM imaging (Figure 4-2). We 
then classified each observed structure as either correct (green circle), damaged/broken 
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(red circle), or containing defects (yellow circle). In this instance, 16HB with defects were 
identified due to the presence of punctate areas of excess stain, which is typically indicative 
of minor abnormalities in DNA structure at that location. Statistical analysis of these 
populations reveals some minor trends in regard to assembly conditions which minimize 
the formation of abnormal structures – lower magnesium concentrations and lower 
annealing start temperatures corresponded to slightly higher yields of correctly folded 
structures, while annealing time and scaffold source had minimal to no effect (Figure 4-3). 
It should be noted that this kind of analysis is very qualitative and requires judgement calls 
over minor aspects in order to categorize structures, limiting the ability to draw really 
significant conclusions based on this data. However, we did choose to move forward with 
using 10mM magnesium, 60°C annealing temperatures, and 18-hour annealing times for 
all future experiments. It is also helpful to note that, while the use of a commercially 
available scaffold strand (IDT) did not produce notably better monomeric structures 
compared to scaffolds produced in the lab, the use of this commercial scaffold did limit the 
assembly of dimer/oligomer structures. While these structures are typically removed 
during purification and thus not particularly relevant to the work, this does point to there 











Figure 4-2: TEM Image Binning of 16HB Populations. Representative TEM image of 
16HBs from defect analysis experiments. All 16HBs were binned based on their 
morphology: well-formed structures (green circles), structures with defects (yellow 




Figure 4-3. Analysis of 16HB Fidelity A) AGE showing assembly of 16HB with different 
annealing temperatures and MgCl2 concentrations; S- p7560 scaffold. B) AGE of 16HB 
annealed with p7560 scaffold obtained commercially (IDT S) or produced in house (Ke S). 
C) Statistical analysis of 16HB populations annealed using different conditions from TEM 
image analysis. 
Finally, we were also interested in testing dynamic 16HB assembly as a means of 
potential driving dynamic MRI signal changes. We designed dimerization strands that 
would bind to the free scaffold loops at the tail end of the 16HB in a manner that would 
link to different 16HBs together in a tail-to-tail orientation. This system produced DNA 
origami rods that were approximately 280 nm long with narrow size distribution, matching 
the expected dimensions of a 16HB dimer (Figure 4-4). Our first dimer strand design 
utilized 3bp sticky-end overhangs to drive dimerization and a 2nt ssDNA gap in between 
the dimerization strands and a filler strand – however, this design only induced ~40% 
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dimerization even after 18-hour reaction times. In order to improve on the dimerization 
efficiency, we redesigned the connecting strands to contain a 5bp sticky-ends with no gap, 
which should improve dimerization efficiency by increasing connection strength via longer 
complementary regions and base-pair stacking. This new design did indeed lead to much 
higher dimerization efficiencies approaching 100%. We then systematically evaluated 
several parameters which would likely influence dimer formation in an effort to identify 
optimal conditions. We found that adding a larger excess of connecting strands (up to 10-
fold excess) led to increased dimer formation, with only modest improvements seen above 
1-fold excess. Increasing the reaction temperature also led to improved dimerization 
efficiency. Finally, we monitored the kinetics of dimer formation, finding that at least 1 
hour is needed at 35°C to produce dimers, and that times longer than 3 hours are needed to 




Figure 4-4. Formation of 16HB Dimers. A) Negative-stain TEM image of 16HB dimer 
structures. Scale bars - 100 nm. B) Distribution of 16HB dimer lengths calculated from 
TEM images (N = 112). C) AGE of 16HB dimer formed with 3bp overhang, including 
dimerization efficiency based on relative band intensity; C - Control 16HB without dimer 
strands. D) AGE of 16HB dimers formed with 5bp overhang at different dimer 
strand:16HB ratios (18 hour, 25°C). E) AGE of 16HB dimers formed at different 
temperatures (10x excess, 1 hour). F) AGE of kinetics of DNA origami dimer formation 




4.4.1.2 DNA-IONP Synthesis 
In order to interface IONPs with our DNA origami structures, we needed to develop 
some form of interaction between the two species. Previous work by our group and others 
using other nanoparticles, such as gold and quantum dots, have established two different 
common methods: hybridization between complementary DNA on the DNA origami and 
nanoparticle surface[165-167], or biotin-streptavidin interactions between biotinylated 
DNA and streptavidin-modified nanoparticles[55, 168]. We investigated both avenues to 
identify which would work best for our IONP system. 
We used commercially available streptavidin-modified IONPs for our initial 
studies. While this system worked, we found that overall yields were relatively low (vide 
infra) and thus sought to find a technique that would work better. Next, we worked on 
synthesizing DNA-modified IONPs. One major challenge in working with IONPs is that 
high-quality, monodisperse iron oxide cores must be synthesized in polar organic solvents 
using hydrocarbon-based stabilization agents such as oleic acid. While these particles are 
highly stable in solvents such as chloroform, their surface chemistry must be altered before 
they can be transferred into aqueous solutions for reaction with DNA. This aqueous transfer 
is done using two different techniques – ligand exchange, in which the hydrocarbon 
stabilizing ligands are replaced with water-soluble groups, or polymer-coating, in which 
amphiphilic polymers are used to coat the hydrophobic nanoparticles and present 
hydrophilic groups on the surface. Our attempts at ligand exchange using catechol-based 
ligands such a dopamine, nitrodopamine, and caffeic acid, which are known to have a high 
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affinity for iron oxide surfaces[169], were unsuccessful due to low stability of the particles 
after exchange (data not shown).  
For the polymer-coating avenue, we first attempted to use commercially available 
IONPs coated with polymers containing reactive groups, such as carboxylic acids and 
primary amines. For IONPs functionalized with carboxylic acid, we used N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide (EDC)/ N-Hydroxysulfosuccinimide (Sulfo-
NHS) crosslinkers to form covalent bonds between the IONP carboxylic acids and amine-
functionalized DNA. Unfortunately, we were unable to synthesize DNA-coated IONPs 
using this technique. While the mobility of IONPs changed during AGE following reaction 
with EDC/NHS, no further changes were observed in mobility or in hydrodynamic 
diameter evaluated with DLS following addition of DNA (data not shown).  For IONPs 
functionalized with primary amines, we used the heterobifunctional crosslinker 
sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC) in 
order to react with thiol-functionalized DNA. We were able to demonstrate shifts in 
electrophoretic mobility of IONPs following reaction with DNA and clear binding to 16HB 
bearing complementary capture sequences (data not shown). However, the samples were 
very messy and controls utilizing Amine-IONPs without reacting to DNA showed binding 
as well, which points to potential electrostatic interactions that complicate the use of this 
method. 
Given these troubles, we turned to a 3rd conjugation chemistry using a ‘Click’ 
chemistry protocol. Click chemistry reactions, particularly those involving reactions 
between alkynes and azides, are widely used due to their reliability, specificity, high yield, 
and mild reaction conditions[170]. The synthesis of DNA-coated hydrophobic IONPs 
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using a click chemistry technique was accomplished by Chad Mirkin’s group, in which a 
wide variety of hydrophobic nanoparticles could be decorated with DNA[164]. The general 
scheme of synthesizing these ‘programmable atom equivalents’ can be seen in Figure 4-5. 
Hydrophobic IONPs are coated with an amphiphilic polymer, poly(maleic anhydride-alt-
octadecene) (PMAO) covalently modified to contain pendant azide groups (PMAO-N3). 
After purification from excess polymer, these particles can be conjugated to ssDNA 
containing a dibenzocyclooctyne (DBCO) group through a copper-free strain-promoted 
alkyne-azide cycloaddition (SpAAC) reaction with the azides on the IONP surface. 
Synthesizing these DNA-coated IONPs (DNA-IONPs) occurs in three steps – IONP 
coating with PMAO-N3, synthesis of DBCO-ssDNA, and conjugation of ssDNA to coated 
IONPs. 
 
Figure 4-5. Scheme of DNA-IONP Synthesis A) Hydrophobic IONPs are mixed with 
azide-functionalized poly(maleic anhydride-octadecene) (PMAO-N3) to create azide- 
coated IONPs, and then mixed with DBCO-modified DNA to create DNA-IONPs. B) 
Strain-promoted Azido-Alkyne Cycloaddition (SpAAC) reaction of DBCO-modified 





In order to coat IONPs with the reactive polymer, a thin film of IONPs and polymer 
is created by evaporating the solvent from a mixture of hydrophobic IONPs and polymer. 
Hydration of the film in an aqueous buffer using sonication produces polymer-coated 
IONPs (either single cores or aggregates) suspended in water. Ultracentrifugation of the 
crude mixture on a sucrose gradient produces 3 bands: a free polymer band visible under 
UV light (with ethidium bromide staining), a well-dispersed IONP band, and a pellet 
consisting of highly aggregated IONPs (Figure 4-6). AGE of IONPs extracted from this 
second band reveal a single product without excess polymer (seen with EtBr staining under 
UV light). Dynamic light scattering measurements show a single peak around 40 nm for 
15 nm IONP cores, though sometimes a multi-modal peak distribution is apparent (with no 
impact of downstream DNA conjugation). The decrease in size following purification is 
likely due to the removal of the large aggregates and clusters during the purification 
process. Finally, negative-stain TEM imaging of the samples reveal well dispersed IONP 








Figure 4-6. Characterization of Coated IONPs. A) Image of sucrose gradient 
ultracentrifugation columns under both white light and UV illumination showing the 
separation of free polymer from coated IONPs from aggregated IONPs. B) White light 
(top) and UV light (bottom) AGE of coated IONPs before and after sucrose gradient 
purification. C) Intensity-weighted size distribution of coated IONPs before and after 
sucrose gradient purification obtained via DLS. D) Negative-stain TEM image of coated 
IONPs after purification. Scale bar - 25 nm. 
 
Further investigation into the coating process revealed several considerations. First, 
and most importantly, we found that the nature of the base solvent used during the coating 
procedure is critically important. The chloroform needs to be free of any polar species, so 
anhydrous chloroform stabilized with molecules other than ethanol is a necessity. Our 
initial attempts at coating using ethanol-stabilized chloroform produced large precipitates 
that would not resuspend in aqueous solutions (Figure 4-7), presumably due to the 
increased polarity of the solution adversely affecting the polarity-driven association of the 
hydrophobic polymer component and hydrocarbon ligands of the particles. Secondly, we 
observed that the underlying quality of the IONPs plays a significant role. We found that 
the same product obtained from the same company but in different lots produced particles 
which had significantly different coating yields, as evidenced by the banding during 
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ultracentrifugation purification. Additionally, we were unable to successfully coat 13 nm 
IONPs synthesized in-house. It is unclear exactly what differences in the particles leads to 
this change – based on conversations with the commercial supplier, the presence of excess 
ligands in the IONP solution could differ and thus purity of the particles could play a role 
in successful coating. Analysis of particles obtained from different bands within the sucrose 
gradient revealed that IONPs which migrate further in the column appear to be clustered 
together, as evidenced by slower electrophoretic mobility and TEM imaging. We tested 
variations in IONP concentration (50 nM vs 100 nM) and polymer excess (300, 450, and 
600 monomer units/nm2 IONP surface area) during coating in order to improve recovery 




Figure 4-7. Troubleshooting of IONP Coating Procedure A) Images of IONP following 
coating in chloroform with two different stabilizing agents, showing aggregation in 
presence of ethanol. B) Image of sucrose gradient columns following ultracentrifugation 
of 3 different populations of coated IONPs, including commercial IONPs purchased from 
same company in different lots (Commercial 1 and 2) and IONP synthesized in-house. C) 
Image of sucrose gradient column (left), negative-stain TEM image (middle) and AGE 
(left, top - white light, bottom - UV light) showing differences in IONP populations 




The SPAAC click reaction used to attach ssDNA to the coated IONP surface 
necessitates the use of a strained alkyne group chemically conjugated to the ssDNA. 
Dibenzocyclooctyne (DBCO) is one such alkyne which is highly stable and participates in 
the cycloaddition reaction with high yield and fidelity. While commercially available 
DBCO-tagged DNA is available from suppliers like IDT, the DNA was very expensive. 
As such, we sought to synthesize this modified DNA ourselves using a reaction between 
amine-labeled DNA and DBCO-labeled reactive esters (Figure 4-8). We successfully used 
both N-hydroxysuccinimide (NHS) and Sulfo-2,3,5,6-tetrafluorophenol (STF) leaving 
groups in this reaction. While no clear differences in the quality of the final DBCO-DNA 
conjugate was observed between these two esters, the use of NHS-esters and a necessary 
DMSO-co-solvent did lead to the formation of a white precipitate during overnight 
reaction. In contrast, the increased hydrophilicity of the STF-DBCO ester allowed this 
reaction to be run entirely in aqueous solution without the need for DMSO and eliminated 
the formation of this precipitate. While the results shown are from experiments using of 
NHS esters, we recommend the use of STF-esters where possible just in case the precipitate 








Figure 4-8. Synthesis of DBCO-modified DNA A) Schematic of reaction between 
activated DBCO-ester and amine-functionalized DNA. B) HPLC trace of eluent at different 
times monitored via absorbance at 260 nm (blue - DNA) and 309 nm (red - DBCO) 
showing separation of 3 different components. C) PAGE gel of amine-DNA (NH-DNA) 
and DBCO-DNA with and without the addition of azide-functionalized FAM fluorophore 
(N3-FAM) without (top) and with (bottom) ethidium bromide staining for DNA. D) UV-
Vis absorbance of amine-DNA (blue) and DBCO-DNA (red) showing characteristic 






Amine-terminated DNA and DBCO-ester were mixed with a 25-50-fold excess of 
DBCO to DNA and reacted in a solution containing PBS and sodium bicarbonate used to 
adjust the pH to optimize the amine-ester reaction. Depending on the ester used, the 
reaction mixture could be entirely aqueous, or 60% DMSO (High concentrations of DBCO-
NHS precipitates at ratios lower than 60%). After an overnight reaction, the resulting 
product can then be purified by HPLC to remove free DBCO and unmodified DNA. 
Purification using ethyl acetate extraction and standard desalting was also sufficient – 
while this technique does not remove any unmodified DNA, we did not find that this 
hindered downstream reactions significantly. In one instance HPLC-purified DBCO-DNA 
appeared to work slightly better in IONP conjugation, but there were not significant enough 
differences to draw firm conclusions. If HPLC purification is available we would 
recommend using that: if not, the extraction/desalting technique works sufficiently and 
does not require any sophisticated equipment. 
HPLC traces of the crude mixtures reveal the presence of three different 
populations: unmodified DNA strands which are eluted at early time points and only show 
up in the 260nm absorbance channel, DBCO-DNA which elute around 20 minutes and 
show both 260nm absorbance (characteristic of DNA) and 310 nm absorbance 
(characteristic of DBCO), and free DBCO esters, which elute much later with absorbance 
predominately at 310 nm. It is unclear why the unmodified DNA elutes as two separate 
peaks – one hypothesis is the formation of DNA dimers during solid phase synthesis, which 
has some supporting evidenced based on secondary bands during polyacrylamide gel 
electrophoresis (PAGE). To verify activity of the DBCO-DNA, the purified product was 
mixed with azide-functionalized fluorescein (N3-FAM). A PAGE gel of the resulting 
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products reveals the presence of a sharp band in the FAM channel only in the DBCO-DNA 
sample, corresponding to the successful reaction between a model azide and the DBCO-
DNA. Finally, UV-Vis absorbance measurements of the DNA before and after conjugation 
with DBCO reveal the appearance of a shoulder at 310nm, which corresponds to attached 
DBCO. 
DNA-IONP Synthesis 
The protocol for conjugating DBCO-modified DNA to N3-PMAO-coated IONPs 
was based on the original publication by Chad Mirkin’s lab and follows closely the 
protocols established for conjugating thiolated-ssDNA to the surface of gold nanoparticles. 
In both cases, the reactive nanoparticles are mixed with the reactive DNA at a sufficient 
excess and the reaction between the two is allowed to proceed overnight. Sodium chloride 
is subsequently added to slowly increase salt concentration – the so called ‘salt-aging’ 
process. High salt concentrations are beneficial for increasing the loading density of DNA 
onto the particle surface by shielding the electrostatic repulsion between neighboring DNA 
strands. However, unmodified particles are typically not stable in very high salt 
concentrations, and thus sodium chloride needs to be added gradually in order to preserve 








Figure 4-9. Characterization of DNA-modified IONPs A) White light AGE of coated 
IONP before and after reaction with DBCO-DNA. B) Intensity-weighted size distribution 
of coated IONPs before (blue) and after (red) reaction with DBCO-DNA. C) UV (top) and 
white light (bottom) AGE of DNA-IONPs mixed with 16HB bearing complementary 
capture strands. D) Negative-stain TEM image of DNA-IONPs bound to 16HB with 2 





The resulting DNA-IONP conjugates were characterized using agarose gel 
electrophoresis and dynamic light scattering. Following conjugation, the particles 
exhibited a sharp decrease in mobility consistent with increased size (Figure 4-9). 
Furthermore, a large shift in the hydrodynamic size was observed following DNA 
conjugation using DLS. Most importantly, we were able to successfully attach DNA-
IONPs to 16HB DNA origami bearing complementary ‘capture’ sequences, as observed 
by both a shift in gel electrophoretic mobility and via TEM imaging. As synthesis of these 
particles had already been published, we did not spend much effort further characterizing 
or optimizing the synthesis. We did however investigate the effect of the final sodium 
chloride concentration reached during the salt aging process. We found that while increases 
in sodium concentration beyond 100mM did not have an observable effect on agarose gel 
mobility (Figure 4-10) or hydrodynamic size (data not shown) of the resulting DNA-
IONPs, differences in DNA loading density became readily apparent while attempting to 
attach DNA-IONPs to the 16HBs in buffer containing magnesium. DNA-IONPs 
synthesized with final sodium chloride concentrations of less than 500mM lost stability in 
10mM magnesium, leading to changes in 16HB mobility as well as smearing of free DNA-
IONPs. It should also be noted that this reaction was very finicky – we found that different 
batches of IONPs or DBCO-DNA would occasionally produce lower quality conjugates, 
as observed by smearing on gel electrophoresis and poor quality of 16HB-IONP products. 
‘Repurifying’ PMAO-IONPs to remove excess polymer using centrifugation typically 
helped, as well as increasing the ratio of DNA:IONP. We also found that conjugation 
reactions were not successful in 1mL volumes. Due to this, conjugation reactions were 




Figure 4-10. Effect of NaCl Titration on DNA-IONP Synthesis A) AGE (white light) 
of coated IONPs after reaction with DNA with the NaCl titration step stopped at different 
NaCl concentrations. B) UV (top) and white light (bottom) AGE images of 16HB with 
complementary capture sequences mixed with DNA-IONPs synthesized with different 





4.4.1.3 16HB-IONP Binding 
In order to attach IONPs to our 16HB, we needed to find some way to engineer 
strong interactions between the DNA origami rod and the IONPs. Traditionally there are 
two main methods used to incorporate heteroelements: the use of streptavidin (STV)-biotin 
interactions and the use of complementary DNA hybridization. For STV-biotin 
interactions, binding of STV-modified heteroelements to biotin-labeled DNA strands on 
the DNA origami structure enable docking of the heteroelements to the prescribed location 
of the modified DNA (Figure 4-11). Commercial biotin-labeled ssDNA is easily 
obtainable, making this a popular choice for systems in which heteroelements can be 
readily conjugated to streptavidin. Core staple strands can be modified with biotin directly, 
or staple strands can contain ssDNA extensions which can hybridize to a separate 
biotinylated strand. While the first option produces more stable systems, the second is 
cheaper, as only one modified strand for all designs needs to be purchased. For 
complementary DNA hybridization, heteroelements conjugated to ssDNA ‘cargo’ strands 
can be attached to DNA origami structures in which staples have been extended with a 
complementary ‘capture’ DNA. This option is generally preferable for several reasons: no 
modified oligos need to be purchased for the DNA origami structure, so designs can be 
potentially cheaper, and different heteroelement populations can be attached to the same 
structure using multiple orthogonal cargo/capture DNA sequence pairs. In both cases, the 
spatial organization of the heteroelements is determined by the specific location at which 
the interacting element (either biotin or capture strand) is located. Careful choice in which 
staples contain these modifications allows for the precise control over heteroelement 






Figure 4-11. IONP-16HB Binding Schematic. Two different techniques were 
investigated for interfacing IONPs with the 16HB. A) Biotin-streptavidin interactions, in 
which streptavidin-modified IONPs bind to biotinylated DNA sequences on the 16HB. B) 
Capture-cargo DNA hybridization, where DNA-modified IONPs bind to complementary 
ssDNA extensions on the 16HB C) Spatial organization of IONPs is controlled by the 





 The 16HB rod contains 36 staples on each face with break points amenable to 
modification with either a biotinylated strand or a capture sequence. We subdivided these 
36 strands in 12 groups of 3, to provide a total of 48 possible binding sites (12 per face) for 
attaching IONPs. The nomenclature for identifying variant designs included the number of 
binding sites (16HB1, 16HB2, 16HB3 for 1, 2 and 3 binding sites), along with the position 
of each binding site labeled from 1-12 (i.e. 16HB2(1,12) refers to a design with two binding 
sites at positions 1 and 12). We chose 3 strands per binding site due to previous work 
demonstrating that multiple tethers per site increase binding yields[166]. We tested both 
streptavidin-biotin and complementary DNA binding strategies – either STV- or DNA- 
modified IONPs were mixed with corresponding 16HB structures and allowed to incubate 
under variable conditions. Successful binding was verified using agarose gel 
electrophoresis, due to a shift in 16HB mobility following attachment of IONPs, and TEM 
imaging of gel-purified structures. TEM imaging in particular allowed for precise 
interrogation of the binding process, as statistics on the number and spacing of IONPs on 
single 16HBs could be identified. In order to study the effect of various parameters on 
IONP binding efficiency, individual 16HBs were binned based on the number of bound 
IONPs or whether or not the 16HB were bridged by IONPs to form dimers or aggregates 
(Figure 4-12). 16HBs which were clearly damaged were omitted from these measurements. 
This allowed us to track which assembly conditions could optimize yields by maximizing 






Figure 4-12. TEM Image of 16HB3+IONP Binning. To calculate binding statistics, TEM 
images were analyzed and each 16HB was binned to either correct structures (green), 
structures with fewer IONPs than designed (blue), and 16HB that had formed 
dimers/aggregates (yellow). Structures that were clearly broken (red) were omitted from 







Streptavidin-IONP 16HB Binding 
We first used commercially-available STV-modified IONPs with a diameter of 10 
nm, as the availability of these particles made it easy to start with. Through this initial 
work, we also found that the quality of commercially available particles can be highly 
variable, and thus it is critical to verify the fidelity of materials received from outside 
sources. Our initial attempts to attach STV-IONPs to biotin-modified 16HB were 
unsuccessful and subsequent analysis revealed issues with the particles themselves, as 
determined by a lack of binding to biotin-modified surfaces (data not shown). We also 
found that the presence of excess free STV was highly variable in these purchased products, 
and thus purification via centrifugation and resuspension in fresh buffer was needed.  
Using this system, we were able to verify STV-IONP binding and elucidate various 
factors that affected this binding. Incubation of 16HBs bearing biotinylated strands at either 
1 or 3 binding sites led to significant reduction in the mobility of 16HB as monitored by 
gel electrophoresis (Figure 4-13). The relative mobility change per heteroelements number 
was significantly larger for these STV-IONPs than other heteroelements used in lab, such 
as gold nanoparticles and subsequent DNA-modified IONPs, which we attribute to the 
surface charge of the particles relative to DNA-coated particles. TEM imaging of purified 
16HB3(1,6,12) samples revealed 16HB with attached IONPs in a mixed population 
containing origami structures bound to 1-3 IONPs and present in dimer or aggregate 
assemblies. Statistical analysis of these populations allowed us to track various assembly 
parameters to identify which produced the highest yield of correct structures – in the case 
of 16HB3(1,6,12) designs, those 16HBs bound to exactly 3 particles. First, we were able 
to show that the number of biotinylated strands at each binding location had a significant 
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impact, with binding yields much higher with 3 tethers per site compared to 1. This matches 
previous work with other nanoparticle heteroelements and is likely due to a combination 
of redundancy in protecting against binding site strand defects as well as increased binding 
cooperativity. We found that the ratio of IONPs per binding site added into the reaction 
also played a role, with excesses greater than 1-fold necessary for higher yields. Based on 
this data, it is unclear if there is much difference between higher-excesses (5x vs 20x) as 
this experiment was not repeated using this system. We also tested the sequence 
dependence of biotinylated-strands attached to the 16HB, finding that there was little to no 
difference based on DNA length. However, in all of these studies the yields were very low 
and highly variable, with the highest observed efficiency around 30%. This poor quality 




Figure 4-13. Commercial STV-IONP Binding Analysis. A) AGE images of 16HB with 
either 1 (left) or 3 (right) biotinylated sites before and after incubation with STV-IONPs. 
B) Representative TEM image of purified 16HB+STV-IONP conjugates. Scale bar - 200 
nm C) Calculation of 16HB3-IONP yields on 16HB with either 3 (blue) or 1 (red) strands 
per binding site. D) Calculation of 16HB3-IONP yields with different ratios of IONP:16HB 
binding sites. E) Calculation of 16HB3-IONP yields with different capture sequence 





We next tried STV-IONPs produced in house (by Sheng Tong in the Bao lab), with 
the thought that these particles might be of higher quality and therefore show better binding 
characteristics. These 8-nm particles were synthesized by introducing reactive groups 
during the polymer coating process and subsequent bioconjugation strategies to attach 
streptavidin molecules to this coating. We were able to verify binding of these particles to 
16HBs bearing biotin-groups using both agarose gel electrophoresis and TEM images 
(Figure 4-14). However, the quality and purity of the conjugates produced were relatively 
poor, as electrophoresis revealed the presence of multiple species within the populations 
as seen by smearing and extra band formation. TEM imaging also revealed significant 
heterogeneity and poor fidelity in the final constructs (data shown for 16HB4, but other 
designs had similar quality). While additional experiments showed that the binding was 
highly conserved across many different conditions, including rapid binding in as fast as 15 
minutes and significant binding with only 1-fold excess of IONPs (data not shown), the 
quality of the assemblies did not ever improve. Based on both of these attempts, we decided 
to move away from utilizing biotin-streptavidin interactions to create the 16HB-IONP 




Figure 4-14. Synthesized STV-IONP Binding Analysis.  A) AGE image showing 16HB 
with different numbers of biotinylated binding sites after incubation with STV-IONPs. B) 




DNA-IONP 16HB Binding 
We used the method developed by Chad Mirkin’s lab for creating ‘Programmable 
Atom Equivalents’ to synthesize IONPs coated with a dense player of DNA that showed 
excellent stability and homogeneity. Mixing these DNA-IONPs with 16HBs bearing 
complementary ‘capture’ staple extensions led to the formation of 16HB-IONP conjugates 
through hybridization-based interactions. We first assembled 10 nm DNA-IONPs 
synthesized by collaborators onto 16HB3(1,6,12) and found that these constructs displayed 
sharp bands with decreased mobility on agarose gel electrophoresis with significantly 
higher binding fidelity (>60% yields) based on TEM images relative to STV-IONPs 






Figure 4-15. Binding Yields of DNA-IONPs Versus STV-IONPs A) AGE images of 
16HB3 before and after incubation with STV-IONP (left) or DNA-IONP (right). B) 
Calculated yields of 16HB3-IONP with either STV-IONP (blue) or DNA-IONP (red). C) 







Figure 4-16. Optimizing Binding of DNA-IONP to 16HB3. Calculated binding yields of 
16HB3+DNA-IONP (left) and AGE images of 16HB before and after IONP incubation 
(right) under a variety of conditions. A) Different magnesium concentrations B) Different 
IONP:16HB-binding-site ratios C) Different temperatures D) Kinetics of IONP binding. 




We next sought to optimize IONP binding fidelity - 15 nm DNA-IONPs were 
mixed with 16HB3(1,6,12) under a variety of conditions and gel electrophoresis and TEM 
imaging were used to quantify binding yields (Figure 4-16). In general, we found that the 
binding reaction is highly robust over the conditions tested, with binding happening rapidly 
(within 15 minutes), occurring with high efficiency even at low IONP fold-excesses (2x), 
and maintaining yields over a range of temperatures (25°C to 40°C). We did find that 
magnesium concentrations during the binding reaction play a role – an increase in 16HB 
with fewer than 3 particles were observed as magnesium concentrations dropped. This 
matches data obtained with other systems[166] and is likely due to enhanced electrostatic 
repulsion between DNA-IONPs and 16HB without sufficient cation screening. However, 
higher Mg concentrations also led to enhanced dimer and aggregate formation.  Other 
experiments were conducted with 10-nm particles and showed similar results. In general, 
there was a decent amount of heterogeneity between samples which makes drawing narrow 
conclusions from these studies challenging – since the experiments were not repeated due 
to IONP shortages, the data is not presented here. The observed variability could come 
from several sources:  the underlying binding reaction itself, damage to structures/IONP 
binding during gel purification and/or TEM grid preparation, or potentially other factors 
we have not thought of. Additionally, there is a chance this data overestimates total yields 
as images were collected from gel purified samples – while every effort was made to cut 
out all observable bands from the gel, there could be free 16HB or larger aggregates which 
were not retained and thus excluded from these statistics. We also were curious to see how 
close these IONPs could be placed together before steric/electrostatic effects limited 
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binding. We used a 16HB2 system with the 2 binding sites spaced at various distances and 
measured yields for both 15nm and 10nm IONPs, finding that binding yields dropped when 
15 nm IONPs were placed closer than 45 nm (Figure 4-17). The use of smaller particles 
did enable closer spacing to be achieved, though a drop in binding yields closer 35 nm was 
still observed for 10-nm particles (data not shown) - it is possible to pack smaller particles 
closer together using this system, but there is a practical limit to how close particles can 




Figure 4-17. Binding Yields of 16HB2 with Different Spacing. Binding yields of 16HB2 






With this improved system, we sought to demonstrate precise control over IONP 
spatial organization. We designed numerous 16HB variants with different numbers of 
binding sites maintaining a constant spacing between each site. We were able to 
successfully bind up to 4 particles with a constant ~35nm spacing using both 10 nm and 15 
nm particles, as well as bind up to 3 particles with a 55nm spacing (Figure 4-18). As the 
number of bound particles increased, the mobility shift observed in AGE also increased. 
We then designed a 16HB with extensions on all 12 binding sites on one face to determine 
maximum binding of 10 nm IONPs. We found that that between 4-5 IONPs could be 
attached – this limitation is likely due to both steric and electrostatic repulsion between 
IONP as well as the bridging of a single IONP across multiple binding sites (Figure 4-19). 
For the 15nm particles, we altered the 16HB design to contain 6 alternating binding sites 
spread across all 4 faces of the rod, giving a theoretical maximum of 24 possible binding 
sites. We found that the maximum number of 15 nm IONPs that could be attached using 






Figure 4-18. Control of IONP Number. Representative TEM images (left), 
measurements of center-to-center distance between IONPs (right) and AGE of different 
16HB before and after IONP incubation. A) 15 nm IONPs with ~35 nm spacing B) 10 nm 










Figure 4-19. Saturated Binding on 1 Face with 10 nm IONPs. A) AGE of 16HB12 with 
and without addition of 10 nm DNA-IONPs B) Frequency distribution of 16HB12 based 








Figure 4-20 Saturated Binding on 4 Faces with 15 nm IONPs A) AGE of 16HB-Full 
with and without addition of 15 nm DNA-IONPs B) Frequency distribution of 16HB12 
based on number of bound IONPs. C) Representative TEM images of 16HB12+10 nm 







We then wanted to demonstrate that we could maintain a constant number of IONPs 
while varying the spacing between particles. We designed 16HB variants in which the 
spacing between binding sites was varied. We found that the spacing between 2 DNA-
IONPs could be tuned between ~20 nm and ~120 nm with ~10 nm spacing using both 10 
nm and 15 nm IONPs, and that the center-to-center spacing between IONPs was identical 
regardless of IONP using the same 16HB2 design (Figure 4-21).  One thing that is 
interesting is the variability of the spacing within each design, as measurements had 
standard deviations of around 8-12 nm. This could be due to general flexibility in the 
dsDNA tethers holding the IONP, the fact that each binding site consists of 3 strands spaced 





Figure 4-21. Control of IONP Spacing. Representative TEM images (left), measurements 
of center-to-center distance between IONPs (right) and AGE of different 16HB designs 
with 2 binding sites before and after IONP incubation A) 15 nm IONPs B) 10 nm IONPs. 
N>100, mean ± s.d. 
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The yields obtained in this work are lower than those obtained with other 
nanoparticle systems. For example, Takabayashi et al found ~97% binding yields for 10-
nm gold particles attached to a DNA origami rod [166] - these yields are comparable to our 
own work using gold nanoparticles. It is not entirely clear why yields with our DNA-IONPs 
are considerably lower – one likely cause is the increased complexity of the nanoparticle 
due to the presence of the hydrophobic ligands and amphiphilic polymer. There is a chance 
that these extra layers might inhibit or complicate binding to complementary DNA 
sequences, though at this point this is mere speculation. The use of this polymer layer also 
limits the inter-particle spacing that can be achieved compared to gold particles as the 
hydrodynamic diameter of the IONPs is larger relative to their core diameter. Regardless, 
the results presented here represent a significant improvement over previous studies that 
have attempted to pattern the assembly of IONPs. Rafati et al decorated DNA origami 
nanotubes with IONPs, but the authors did not demonstrate any modulation over the 
number and spacing of the IONPs[161]. Ryu et al were able to control the number of IONPs 
bound to a single dsDNA using Zinc-finger binding proteins – however, their system 
produced clusters with much higher polydispersity and they did not demonstrate any ability 
to modulate inter-particle distances[109].  
4.4.1.4 16HB-IONP Purification 
In order to measure the effect of IONP spatial organization on T2, excess IONPs 
used during assembly need to be removed. As such, we needed to develop a method for 
purifying the assembled IONP-16HB from the free IONPs before conducing the 
measurements. Purification using gel electrophoresis is the typical method used for 
purifying excess heteroelements and works well for small-scale purifications used for 
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studies such as binding yield analysis. However, a large quantity of sample (~1mL of 1-
2nM 16HB) is needed for NMR measurements, and gel electrophoresis has neither the 
throughput nor the yield to be sufficient for this kind of preparation. We investigated the 
use of PEG precipitation as a method for removing excess IONPs, but free IONPs also 
pelleted in the same conditions as the 16HB (data not shown). Other techniques, such as 
ultracentrifugation and ultrafiltration, are also insufficient due to the large size of the 
IONPs. We tried using size exclusion chromatography, but this technique proved to be very 
challenging and time consuming (data not shown). Finally, we used a modified version of 
a technique first reported by Shaw et al in which magnetic beads are used to separate bound 
origami structures from free heteroelements[171]. Due to concerns regarding the use of 






Figure 4-22 Schematic of Bead Pulldown Purification Method. A) Method for release 
of 16HB from polymeric beads where 16HB is initially bound (left) and addition of a 
release strand binds to available toehold (middle) with subsequent branch migration 
displacing 16HB from bead (right). B) General design of anchoring strand, containing a 
polyA particle binding domain (grey), a 10-nt toehold region (red) and a domain 
complementary to DNA origami scaffold (blue). C) General design of release strand, 
containing 10-nt toehold complement (red) and polyT release domain (grey). 
In this technique, DNA origami structures contain a sacrificial ‘anchoring’ strand 
which can hybridize to DNA-functionalized micron-sized polymer beads (Figure 4-22). 
These polymer beads could then be isolated from particles in solution through low-speed 
centrifugation, leading to the formation of a pellet consisting of DNA origami/polymer 
beads. Species without an anchor DNA strand (i.e. all unbound heteroelements) are left in 
the supernatant and can be removed. Repeated washing/pelleting steps can be conducted 
in order to remove a large portion of free heteroelements. The second step involves the 
release of the captured DNA origami-heteroelement conjugates from the polymer beads 
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through the use of a strand displacement reaction. The anchoring strand contains 3 different 
domains – a scaffold binding domain, a particle binding domain, and a single-stranded 
toehold domain. A ‘releasing’ strand is then designed with a sequence complementary to 
both the toe-hold domain and the particle binding domain. Hybridization of the release 
strand to the anchoring strand via the toe-hold domain subsequently leads to strand 
displacement via a branch migration process and a release of the DNA origami from the 
polymer beads. A final pelleting step is then used to isolate the free polymer beads from 
the released DNA origami conjugates, which can then be collected.  We designed an 
anchoring strand to contain a scaffold-binding domain complementary to free scaffold 
loops on the ends of the 16HB, a 10-nt toe-hold domain, and a 25bp particle binding 
domain, along with a release strand containing a 10-nt toehold complement domain and a 
domain identical to the sequence on the polymer beads. We made use of commercial 
polymeric beads designed for use in purifying mRNA from cell lysate via hybridization to 
the polyA caps of mRNA – thus, our particle binding domain was a polyA sequence 
complementary to the polyT on the polymeric beads, and our release strand consisted of a 
polyT sequence. 
In a traditional experimental set-up, 16HB (with and without bound IONPs) were 
incubated with polymer beads, washed several times, and then released. In order to quantify 
recovery yields using this method, aliquots from the first supernatant (S) and the released 
mixture (R) were run on an agarose gel alongside an aliquot of the original solution and 
the relative intensity of each band could then be compared in order to estimate relative 
concentrations. Thus, yields were calculated as the percent of the original concentration 
that was in each aliquot. It should be noted that calculations of yields in this matter are only 
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semi-quantitative, and thus the numbers presented represent a general overview of the 
efficiency of recovery and differences between similar numbers are likely meaningless.  
Furthermore, the recovered quantities in both the supernatant and release aliquots rarely 
added up to 100%, which implies that some portion of structures remained bound to the 
beads even after addition of the releasing strand. Whether this is due to non-specific 
binding or incomplete strand-displacement reactions is not known. 
Initial studies were conducted using cellulose-based polymeric beads. 
Unfortunately, significant non-specific binding of DNA in the presence of magnesium was 
observed, and thus yields of recovered 16HB structures was very low (data not shown). 
We then tried polystyrene-based beads, which showed significantly less non-specific 
binding and thus higher yield of recovery. We investigated the efficacy of the release step 
under different conditions using free 16HB and found that 37°C and at least 2 hours of 
incubation was required for sufficient release and subsequent recovery (75-100% recovery 
yields) (Figure 4-23). These limitations are likely due to the kinetics of the strand 
displacement reaction, which must reach completion in order for the 16HB to be released. 
By varying the number of polyA anchoring strands between 0 and 4, we were able to verify 
that the presence of anchor strands is required for purification, and that further increases in 
the number of strands leads to both higher initial binding (fewer 16HB in supernatant) but 
also less efficient particle recovery (fewer 16HB in release aliquot). We also found that the 
concentration of magnesium during binding and release had minimal effect on recovered 
yields, which imply that cation-mediated non-specific binding is likely not an issue leading 





Figure 4-23. Factors Affecting 16HB Release from Polymer Beads. AGE of 16HB 
binding and recovery from polymeric beads along with band intensity analysis to estimate 
relative yields. C - Control, stock 16HB solution, S1 - Supernatant from first wash step, R 
- Supernatant following 16HB release. A) Only release supernatant after 2 hours at 
different temperatures B) Release kinetics at 37 °C C) Titration of the number of polyA 




After initial tests using free 16HB were conducted, we then turned to testing to see 
how well 16HB bound with IONPs could be purified using this method. While initial 
attempts were successful, we did find that yields with particles were lower than yields 
without particles. More importantly, we found that the position and number of IONPs 
attached had a significant effect on the recovery yields from purification (Figure 4-24). 
Yields were practically non-existent when attempting to purify 16HB bound to 3 IONPs. 
Furthermore, yields also decreased when IONPs were placed closer to the site of 16HB-
bead binding and the strand displacement reaction (site 1 vs site 6). Based on these results, 
why hypothesize that steric effects from local IONPs hinders the strand displacement 
reaction from occurring.  
 
Figure 4-24. Effect of IONP Placement on 16HB Recovery - 25pA Binding.  AGE of 
16HB binding and recovery from polymeric beads along with band intensity analysis to 
estimate relative yields. C - Control, stock 16HB solution, S1 - Supernatant from first wash 
step, R - Supernatant following 16HB release. 16HB designs with different binding 




We next investigated other anchor-strand designs in order to see if a new strategy 
could lead to higher recoveries of 16HB bound with higher numbers of IONPs. We first 
investigated decreasing the length of the polyA domain of the anchor strand, with the 
hypothesis that shorter domains would lead to higher yields. In particular, we chose lengths 
with estimated melting temperatures in between the temperature used for binding (25°C) 
and the temperature used for release (37°C): 13-nt (30°C), 14-nt (34°C), and 15-nt 
(36.5°C). We also tried putting either 2 or 4 copies of the 25pA binding domain on the 
remaining free scaffold loop protruding from the middle of the structure. When testing free 
16HB, we found that all the shorter domains gave comparable yields with high binding, 
while full length domains on the free scaffold loop had lower binding efficiency and 
slightly worse release efficiency (Figure 4-25). During these experiments, we also noticed 
that the beads were sticking to the side of the tubes and sample was lost during pipetting. 
In order to remedy this, we started using the 1xFoB10 buffer supplemented with 0.01% 
Pluronic-F-127 in an effort to minimize non-specific binding to the tube, which led to a 
further improvement in yield. Since the new mechanism for release using the 13-nt polyA 
binding domains was theorized to be based on temperature induced melting rather than 
strand displacement, we conducted an experiment in which 16HB release was monitored 
both with and without the addition of release strands. We found that while some release 
does occur without the presence of release strands, consistent with thermally-induced DNA 
melting, the use of release strands did still have a significant effect. We hypothesize this is 
due to release-strand/anchor strand binding that occurs immediately upon removal of the 
sample from the oven but prior to centrifugation, which could prevent rebinding of 16HB 






Figure 4-25. New Anchor Strand Design for 16HB Recovery. AGE of 16HB binding 
and recovery from polymeric beads along with band intensity analysis to estimate relative 
yields. C - Control, stock 16HB solution, S1 - Supernatant from first wash step, R - 
Supernatant following 16HB release. A) Recovery of 16HB from polymer beads using 
different anchor strand designs, including different length polyA domains or anchor 
domains attached to free scaffold loop (FL). B) Recovery of 16HB with two different 
anchor strand designs in the presence of Pluronic F-127. C) Recovery of 16HB using 13pA 






Based on these results, we moved forward with using the 13-nt polyA binding 
domain located on the free scaffold loops at the end of the 16HB. We tested this new design 
with 16HB bound to a wide range of particles and found that reasonable recovery yields 
(>50%) could be obtained with all designs, including structures with IONP bound adjacent 
to anchor strands and structures with large numbers of IONPs (16HB12, with ~4-6 IONPs) 
(Figure 4-26). It should be noted that large scale purification using this bead pulldown 
method (I.e. 200uL at 1.5nM) does induce some degree of aggregation/dimerization of 
16HB’s relative to gel purification, with around 20-25% of 16HBs found to be in some 
higher-order network. This is compared to aggregate yields in the 5-10% range for gel 
purified structures. We hypothesize that this is due to the significant concentration of 
16HB-IONP constructs that occurs during the pelleting procedure, which could be leading 




Figure 4-26. Effect of IONP Placement on 16HB Recovery - 13pA Binding. AGE of 
16HB binding and recovery from polymeric beads along with band intensity analysis to 
estimate relative yields. C - Control, stock 16HB solution, S1 - Supernatant from first wash 
step, R - Supernatant following 16HB release. 16HB with different numbers and positions 
of bound IONPs were analyzed. 
4.4.1.5 T2 Measurements of 16HB-IONP Assemblies 
After IONPs have been assembled on the 16HB and purified from excess IONP 
using the bead pull-down method, the next step was to monitor the effect of assembly on 
T2/r2 measurements. We used a time-domain 1D nuclear magnetic resonance machine, 
which can be programmed to run through a CPMG pulse sequence mimicing that used in 
traditional T2-weighted MRI imaging to calculate signal intensity vs echo time, allowing 
T2 to be extracted from the curve using an exponential fit. By calculating T2 at several 
different concentrations (i.e. serial dilutions) of the same sample, r2 can be calculated 
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through a linear fit of 1/T2 vs concentration.. There is some concern over the reliability of 
these measurements primarily due to the specifics of the NMR machine that was available 
for use at Georgia Tech, as the machine was very old with suboptimal temperature control. 
Significant effort went into to identifying optimal operating procedures to minimize 
measurement variability (data not shown), and comparisons to measurements made with a 
more appropriate instrument (Bruker MiniSpec) show that data collected in this manner is 
reliable enough for this work. 
In order to calculate r2 values and compare the effect of assembly across multiple 
different samples, the exact concentrations of each sample must be known. While this is 
typically not a problem for traditional IONP contrast agents, which can be prepared in large 
quantities and are easily manipulated, the nature of the 16HB-IONP preparation and 
purification made accurate concentration measurements very challenging. The buffer 
necessary for 16HB-IONP assembly and stability (Tris, EDTA, and Magnesium) was not 
compatible with the standard colorimetric assay used in our lab to measure iron 
concentrations. Furthermore, the concentrations of samples immediately following 
purification were below the detection limit of this assay. As such, post-processing 
involving the heat-induced degradation of 16HB, centrifugation, and 
resuspension/concentration in pure water was needed. This process introduced its own 
variability, which combined with the native variability of the ferrozine assay by itself and 
the small sample volumes preventing repeat measurements, made the accurate 
determination of concentration unreliable. We also tried to use inductively coupled plasma-
optical emission spectroscopy through the use of a core facility at University of Georgia, 
but test measurements on our samples revealed significant variability here as well. As such, 
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we developed a concentration-independent method for monitoring the effect of IONP-
assembly. Because these structures are not stable at high temperatures due to melting of 
the DNA double-helices, heating of the structures destroys the underlying assembly, 
freeing the particles to behave like individual, un-assembled IONPs (Figure 4-27). By 
measuring T2 before and after heating of the samples, we can directly probe the effect of 
assembly on T2 irrespective of concentration, as the concentration of particles stays the 
exact same before and after heating. Furthermore, we can calculate the change in r2 due to 
assembly by measuring T2 values before and after heating of a serial dilution of 16HB-
IONP samples and plotting the values before and after heating with arbitrary concentration 
values – since we are only looking at difference between r2 values rather than the actual 
value itself, this process gives the exact same value (percent change following heating) 
regardless of what concentration is used for the calculation. However, as a reference we 
were able to calculate the exact value of r2 for 15nm IONP samples since the concentration 
of the stock mixture was known – 138 mM-1s-1 - thus r2 values of the other assemblies can 




Figure 4-27. Effect of Heating on 16HB-IONPs. Representative TEM image of 16HB-
IONP samples A) before and B) after heating to 85°C. 
T2 changes with Streptavidin-IONP 
We first monitored the effect of 16HB-mediated assembly on T2 using the 
commercial 10 nm STV-modified IONPs. Because yields of the assembly were so low, we 
were skeptical that any difference could be seen between small changes in IONP number. 
We thus compared 16HB designs containing either 3 binding sites  or 12 binding sites. We 
found that assembly had a significant effect on T2 relaxivity of the assemblies, where the 
16HB3 design led to a ~20% increase in r2 and the 16HB12 design led to a ~40% change 
in r2 (Figure 4-28). Interestingly, we did find a small change in r2 following heating of the 
free IONPs. However, this value is not statistically different than 0, and there are likely 
some measurement error or other small effects that could be leading to this change. 
Repeated measurements of the same sample did show a slight drift in T2 values, so issues 




Figure 4-28. Effect of STV-IONP Assembly on T2. Relative change in T2 before and after 
heating of free IONP (blue), 16HB3+IONP (red), and 16HB12+IONP (green) along with 






T2 changes with DNA-IONP 
We then tested 16HB-IONP assemblies using DNA-IONP, which produced 
conjugates with much better yields. We also switched to use 15 nm IONPs, allowing us to 
use lower 16HB concentrations during measurements and thus made the sample 
preparation for these experiments easier. In order to investigate the effect of IONP number 
on T2 relaxivity enhancement, we used 16HB designs with either 1, 2, or 3 binding sites 
with ~50nm spacing between particles (16HB2-1,6 and 16HB3-1,6,12). We found that 
these small changes in the number of IONPs led to significant alterations in r2, with 2 bound 
IONPs producing a ~10% increase in r2 and 3 bound IONPs producing a ~20% increase in 
r2 (Figure 4-29). As with the previous experiment using STV-IONPs, we did find that there 
was a small change in 16HB with 1 bound IONPs following heating, though this change 
was not statistically different than 0%. In order to identify the maximum enhancement 
efficiency possible using the 16HB system, we also designed a structure in which the 
binding sites on all 4 faces were saturated. Using this system, we were able to observe a 
140% increase in r2 values for samples with an average 8 IONP/cluster (Figure 4-30). We 
also compared 16HB with 1 bound IONP to free IONPs and found that there was no 
significant difference, implying that the presence of the 16HB did not have any effect on 
the relaxivity of the particles (Figure 4-31). The samples used for NMR measurements 
were somewhat heterogeneous - we found that ~50% of all IONPs were present in the 
correct formation, with an average of 1.6 IONP/cluster for the 16HB2 assembly and 2.7 
IONP/cluster for the 16HB3 design. Unfortunately, there was a significant number of free 





Figure 4-29. Effect of the Number of DNA-IONP Assembly on T2 relaxivity. A) 
Relative change in T2 relaxivity before and after heating of 16HB1 (blue), 16HB2 (red), 
and 16HB3 (green) with attached IONPs along with representative TEM images. N=3, 
mean ± s.d., * p<.05, ** p<.005 B-C) Distribution of IONPs based on cluster size for B) 








Figure 4-30. Effect of Maximizing DNA-IONP Loading on T2 Relaxivity. A) Relative 
change in T2 relaxivity before and after heating of 16HB-Full + DNA-IONP along with 
representative TEM images. B) Distribution of IONPs based on cluster size along with 




Figure 4-31. Effect of 16HB on T2 Relaxivity of Single DNA-IONPs. A) Relative change 
in T2 relaxivity before and after heating of 16HB with 1 IONP (blue) or free IONPs (red) 
along with representative TEM images. N=3, mean ± s.d. n.s. p> .05 
 
Next, we investigated the effect of IONP spacing on r2 enhancement. We designed 
three 16HB structures with 2 binding sites, spaced either 40nm (16HB2-1,5), 70nm 
(16HB2-1,8) or 100nm (16HB2-1,11) apart. Unfortunately, closer spacing than 40 nm was 
not feasible due to the significantly decreased yields at these distances. We found a minor 
effect, if any, on the modulation of r2 in respect to spacing for these three samples. (Figure 
4-32). There was no statistical difference between 40-nm and 70-nm spacing, and while 
there was a statistically significant difference between the 100 nm spacing and the others, 
this was still a relatively minor change. Differences in the yield of different populations 
across each sample could be shielding any effect due to spacing – for example, the 40nm 
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spacing sample had higher single IONP clusters and fewer aggregated IONP clusters, 
which could be artificially decreasing the observed r2 enhancement relative to the 70nm 
spacing sample. There is a chance that changes due to IONP spacing could be observed if 
samples with higher purity and/or closer spacing could be produced. However, given the 
relatively small predicted enhancement at these spacing, it is likely that clear differences 
will be too difficult to observe experimentally. 
 
 
Figure 4-32. Effect of DNA-IONP Spacing on T2 Relaxivity. A) Relative change in T2 
relaxivity before and after heating of 16HB-2 + DNA-IONP with different spacing (Blue - 
115 nm, Red - 75 nm, Green - 45 nm) along with representative TEM images. B) 





In relation to previous experimental studies, the maximum r2 increase we have 
observed is comparable to that observed using other clustering methods. For example, we 
found ~100-120% increases in r2 in our previous work (Chapter 3) with both 8 and 15 nm 
IONPs[145]. Other groups have found similar increases between 150-160% for the largest 
clusters[86, 87]. Perhaps most interesting, the enhancement values we observed are 
significantly larger than those from the studies using the most similar clustering systems, 
namely the bacteriophage and dsDNA systems [109, 160]. Using the bacteriophage system, 
the researchers surprisingly showed no significant increases in r2 despite an apparent large 
number of bound IONPs. Similarly, Ryu et al only showed a ~10% increase in r2 when 
attaching ~11 IONP to their dsDNA template. It is unclear exactly why these studies 
showed such small changes in r2 enhancement relative to our work and others. One 
potential explanation could be the large r2 values of the free IONPs used by Ryu et al, 
which started at 288 mM-1s-1 relative to our 130 mM-1s-1, and that the large percent increases 
only occur with less efficient single IONPs.  
 In relation to the previous theoretical studies, direct comparisons are challenging 
due to both the reported parameters (R2 for theoretical work vs percent change in r2 here) 
as well differences in spacing/number combinations. For example, Brown et al found a 
power law relationship of R2 = N0.44, which predicts a ~35% increase with 2 particles and 
a 62% increase in a system with 3 particles[105], much higher than that found in our system 
(10% and 20%, respectively). This difference could come from several factors – in their 
simulation Brown et al used particle clusters with much closer inter-particle distances, 
which is predicted to also lead to increases in relaxivity. Furthermore, the presence of 
heterogenous sub-populations in our system, including free IONPs and 16HB with only 2 
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bound IONPs, could leave to a diminished observed signal in our system. Our work also 
shows a much larger effect for 8 particles than would be predicted based on changes in 2 
and 3 particles, which also does not match the predicted power law relationship: again, this 
comparison is complicated by the simultaneous change in IONP distance in our 
experiments. However, the 8 particle system with closer spacing did match the predicted 
enhancement. Our results also matched a 3 particle simulated system with 40 nm spacing. 
Similarly, the predicted change in a 2-particle system from this work is larger than what 
we observe at a given spacing. Work by Matsumoto et al show changes in R2 to be 23%, 
15%, and 11% at the 40nm, 70nm, and 100nm spacing used in our study[84]. However, 
these simulations were conducted using systems of 3 particles, which should produce larger 
relative changes compared to a system of 2 particles used in our experiments. Future work 
with larger DNA structures to facilitate construction of clusters with both higher numbers 
of evenly spaced particles and changes in spacing between 3 particle systems would be 










Figure 4-33. Dimerization and Dynamic T2 Changes with 16HB-IONP. A) AGE image 
of 16HB2(1,6) with attached IONP before (C) and after (+Dimer) the addition of 
dimerization strands and incubation at 35°C for 3 hours. B) Representative TEM image of 
16HB2(1,6)+IONP dimer. C) R2 of 16HB2(1,6) samples after incubation at 35°C following 
addition of dimerization strands at different time points. R2 values of samples were 
normalized to sample without the addition of dimerization strands. R2 ratio was also 






Dynamic Modulation of T2 Enhancement 
Finally, we were interested in using dynamic changes in the assembly of our 16HB 
to drive dynamic changes in T2 relaxivity, much like the magnetic resonance switches 
developed by others. We used the 16HB dimer system developed previously – addition of 
connecting strands to a sample of 16HB-IONP should lead to dimerization of the 16HB, 
an increased in the number of IONPs per cluster, and a subsequent change in R2 (1/T2). We 
found that addition of connecting strands to solutions of 16HB2(1,6) with attached IONPs 
did lead to the formation of dimerized structures, as observed by a shift in AGE mobility, 
and TEM imaging validated the formation of 300 nm long 16HB rods containing 4 bound 
IONPs (Figure 4-33). For NMR measurements, we prepared two identical solutions of 
16HB2+IONP and measured T2 for each sample. We then added dimerization strands to 
one of these solutions and continued to measure R2 values overtime for these solutions. We 
normalized R2 values of 16HB-IONP + dimer to control samples, and found that R2 
increased over time, with a maximum enhancement of ~13% after 24 hours. When 
normalized to initial T2 measurements, the R2 value of the dimerized sample increased 
overtime while the control sample actually decreased – this phenomenon is likely the same 
as observed for r2 changes in free IONPs after heating and due to issues with the NMR 
machine. After heating of the samples, the R2 values returned to identical values which 
indicates that the IONP concentrations were the same between samples and that all R2 
increases were due to dimerization-induced increases in IONPs/cluster. Analysis of the 
sample after 24 hours by AGE and TEM revealed significant aggregation of the dimerized 




4.5 Conclusions and Future Directions 
In this work, we’ve demonstrated a novel method for controlling the spatial 
organization of IONPs. This technique offers the unprecedented ability to modulate the 
spacing and number of IONPs with a high degree of precision and control. With this 
system, we demonstrated how single particle additions to clusters can lead to r2 
enhancement, with maximal enhancement on par with other clustering-based techniques. 
This system can now serve as a modular platform that can be further adapted and improved 
to allow for a number of other parameters to be investigated. Additionally, we have also 
demonstrated one of the first integrations of magnetic nanoparticles with DNA origami, 
and the first to demonstrate functionality using this system. These constructs can offer a 
new method for tracking the fate of DNA origami nanostructures in vivo using MRI, 
facilitating further studies into the use of DNA nanoparticles as drug-delivery vehicles. 
   Considering most of the experiments done in this thesis served primarily as a proof-
of-concept demonstration of a novel technique, more work can be done to further 
understand the details of the DNA-origami mediated assembly of IONPs. For example, it 
would be interesting to see how the trends observed here would change if IONPs with 
different sizes are used. There are also a number of new parameters that can be evaluated 
by using different DNA origami nanostructures - for example, the use of a 400-nm long 
6HB rod would facilitate the incorporation of larger numbers of IONPs with increased 
inter-particle spacing. We could then evaluate if continual increases in IONP number will 
follow a power law relationship with T2 relaxivity as predicted by theoretical models, or 
identify a maximum inter-particle spacing at which the increase in r2 is lost. More complex 
DNA origami nanostructures can also be used to vary the geometric arrangement – for 
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example, hexagonal tiles previously developed by our lab could be used to test circular and 
2D planar assemblies, while polyhedral structures could be used to test spherical/shell 
orientations. More in-depth studies into the dynamic assembly to drive T2 changes are also 
needed to optimize this procedure. Further improvements in the technical aspects of this 
work could be done. A better understanding of the synthesis of azide-PMAO is needed, as 
we were unable to replicate the synthesis and thus were limited in the quantity of particles 
we could synthesize – future work will require the ability to create this polymer in-house. 
Improvements in the yield of IONP binding could also help to provide a clearer 
understanding of the r2 enhancement effects by eliminating side products that could dilute 
the signal, while alterations in the IONP themselves to allow for closer packing would be 
helpful for validating large r2 increases predicted to occur at small inter-particle distances.  
Finally, there is promise for these IONP-DNA constructs to be used as sensing elements 
based on the stimuli-directed assembly/disassembly of the 16HB. Dynamic changes linked 
to a specific stimuli such as pH or clinically-relevant mRNA would enable these structures 
to be used as in vitro sensing probes or in vivo molecular imaging contrast agents. The use 
of ultrasmall IONPs would potentially enable switching between T1 and T2-dominate 
contrast generation, which would have improved clinical relevance. As such, it would be 
especially interesting to try to evaluate the in vivo behavior of these nanostructures, though 




CHAPTER 5. SYNTHESIS OF ROLLING NANOSCALE DNA 
MOTORS 
5.1 Abstract 
There is considerable interest in the development of synthetic molecular motors that 
can recapitulate the directed motion of protein machines within cells. DNA walkers have 
shown promise as molecular motors with highly tunable properties and simplified design. 
However, these walkers exhibit slow velocities and limited processivity relative to proteins, 
limiting further expansion of their applications. Here we demonstrate a nanoscale motor 
made entirely of DNA using the DNA origami technique that exhibits a unique rolling 
motion, enabling speeds of up to 200 nm/minute and total displacements on the micron 
scale. By leveraging the unique capabilities of DNA origami, we independently assess the 
impact of polyvalency, motor domain density, and rigidity on the behavior of these motors. 
We anticipate that the DNA origami machines presented here will have uses in a variety of 
applications, including biosensing, molecular robotics, and DNA computing. 
5.2 Attribution of Effort 
I would first like to note that the work presented in this chapter was the result of 
a collaboration with Dr. Khalid Salaita’s lab at Emory University. The work done was 
shared equally between myself and Alisina Bazrafshan. Alisina was the one who did 
everything related to the microscopy work – he conducted the experiments, analyzed the 
data, and created the figures related to this part of the study. As such, he deserves major 
credit for a significant portion of this portion of the thesis. The results presented here 
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will likely be published soon, with many figures taken directly from the manuscript – 
given that this thesis will be submitted prior to that, I unfortunately am not able to cite 
the specific publication. 
5.3 Introduction 
Directed motion at the molecular level plays a critical role in a wide variety of 
biological functions, including intracellular transport and mitosis[110-112]. There has 
been considerable interest in developing synthetic motors inspired by these biological 
machines for use as model systems for studying natural processes as well as for technical 
applications, such as biosensing, molecular computing, etc. [113, 114]. Of the various 
types of synthetic motors that have been created, DNA walkers are some of the most 
studied – the precise programmability of DNA makes it an excellent material for 
constructing nanoscale motors and machines[2]. DNA-walkers have been designed 
using numerous different strategies for inducing motion along a track, and have been 
used to perform a variety of tasks [121, 122, 127, 132, 140, 144, 172, 173].  
 While DNA-based machines that walk along a track have shown the greatest 
promise in recapitulating the properties of biological motor proteins, these motors are 
limited to slow velocities, limited processivity, and limited programmability. Increasing 
the number of connection points between walker and track can limit spontaneous 
dissociation and improve motor endurance, but this increased polyvalency leads to a 
significant decrease in motor velocity[129]. One exception to this trade-off is the rolling 
behavior of highly polyvalent DNA-coated silica microparticles[130]. The process of 
rolling, which reduces DNA motor footprint by limiting unproductive sampling 
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interactions, represents a fundamentally distinct type of movement that overcomes the 
documented trade-offs inherent to other multivalent molecular motors.  
We sought to engineer highly-tunable nanoscale motors exhibiting this rolling 
motion using DNA origami. DNA origami has emerged as one of the premier methods 
to precisely control nanoscale features and has been used to construct a wide variety of 
intricate one-, two-, and three-dimensional nanostructures and molecular machines[1, 8, 
174]. To the best of our knowledge, dynamic DNA origami structures have only been 
used to construct machines which undergo local relative motion to apply work on their 
surroundings, or as a landscape to facilitate the movement of other molecular walkers 
[175].  We hypothesized that DNA origami could be used to create nanoscale motors 
with increased control over every aspect of the design process, facilitating the 
construction of faster, unidirectional nanoscale DNA motors with tunable motion. 
Furthermore, we can capitalize on the global addressability of DNA origami to 
experimentally determine the roles of polyvalency and distribution in DNA motor 
movement through precise engineering of the location of the DNA ‘feet’[176].  
 Here we demonstrate for the first time a DNA origami nanostructure that acts as a 
DNA motor, processively converting chemical energy to mechanical motion. We designed 
a polyvalent 16 helix bundle (16HB) DNA origami nanostructure that moves thousands of 
nanometers via a rolling mechanism and can be programmed to carry cargo strands at 
multiple sites. These motors roll on a straight line for thousands of body lengths with 
velocities up to 200 nanometers per minute. Additionally, we are able to decouple the 
relationship between DNA leg density/polyvalency and demonstrate that tuning the density 
of the DNA legs maximizes the velocity and distance travelled of nanoscale rolling motors. 
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Finally, we show that the rigidity of the motor is an important driver of the super-diffusive 
motion of these DNA origami motors. 
5.4 Materials and Methods 
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. Stock 
solutions were made using Nanopure water (Barnstead Nanopure system, 
resistivity = 18.2 MΩ), herein referred to as DI water. All oligonucleotides were 
purchased from Integrated DNA Technologies. RNase H was obtained from Takara 
Clontech. Ibidi Sticky-Slide VI 0.4 channels and TeraspekTM Microspheres were 
purchased from Thermofisher. NHS-PEG4-azide was purchased from Click Chemistry 
Tools. 
5.4.1.1 Optical Microscopy 
The microscope was equipped with an Intensilight epifluorescence source (Nikon), 
a CFI Apo 100 × NA 1.49 objective (Nikon), and a TIRF launcher with three laser lines: 
488 nm (10 mW), 561 nm (50 mW), and 638 nm (20 mW). The microscope also included 
a Nikon Perfect Focus System, which allows the capture of multipoint and time-lapse 
images without loss of focus. All of the reported experiments were performed using the 
Quad Cube (97327), TRITC (96321) filter cube set supplied by Chroma. 
5.4.1.2 Super-resolution Imaging of the Fluorescence-Depletion Tracks 
SIM images were acquired on a Nikon N-SIM system equipped with a CFI Apo 
×100 1.49 NA objective and an Andor iXon EMCCD (60 nm per pixel). For each N-SIM 
image, nine images of a 3′-Cy3-RNA sample were acquired in different phases using a 561 
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nm laser as an excitation source and were reconstructed using the Nikon Element software 
package. 
5.4.1.3 Fabrication of RNA monolayers  
A No. 1.5 glass slide (25 × 75 mm) was cleaned by sonication in DI water for 15 
minutes in 200 proof ethanol for 15 minutes and was subsequently dried under a stream of 
N2. The silicon glass was etched by piranha solution (v/v = 3:7 hydrogen peroxide/sulfuric 
acid) for 30 min to remove residual organic materials and activate hydroxyl groups on the 
glass. The cleaned substrates were rinsed with DI water in a 200 mL beaker for at least 6 
times and further washed with ethanol thrice. Slides were then transferred to a 200 mL 
beaker containing 2% APTES in ethanol for 1 h, washed with ethanol thrice, and thermally 
cured in an oven (~110oC) for 10 min. The slides were then mounted to 6-channel 
microfluidic cells. To each channel, ~50 µL of 10 mg/mL of NHS-PEG4-azide in 0.1 M 
NaHCO3 (pH = 9) was added and incubated for 2h. The channels were washed with 1 mL 
DI water thrice and the remaining water in the channels was removed by pipetting. DNA-
functionalized slides were prepared using a copper-catalyzed azido-alkyne cycloaddition 
reaction - after thoroughly rinsing the surface with deionized water, a solution of 10 µM 
alkyne-modified DNA (anchor strand), 500 µM THTPA, 200 µM CuSO4 and 5 mM sodium 
ascorbate in 1 M potassium phosphate buffer was added to the surface. The surface was 
treated with water and PBS to remove excess amounts of DNA that were not conjugated to 
the surface. The chamber was then sealed by Parafilm to prevent evaporation. After 
incubation, excess DNA was removed from the channel using a ∼5 ml DI water rinse. 
Lastly, the RNA substrate was immobilized to the surface through hybridization of 100 µl 
of a complementary RNA/DNA chimera (100 nM) in 1 × PBS for 12 hours. The wells were 
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sealed with Parafilm for each step to prevent evaporation and the resulting RNA monolayer 
remained stable for weeks, as determined by fluorescence imaging. 
5.4.1.4 Determining RNA Surface Density 
RNA surface density was determined by releasing the Cy3-tagged RNA from the 
surface by adding 100 µl of RNase A (100 µg ml–1 in 1 × PBS) and then quantifying the 
Cy3 fluorescence intensity in solution using a calibration curve obtained with the 
fluorescence microscope. 
5.4.1.5 Synthesis, Purification, and Characterization of 16HB Origami Structures 
Single-stranded scaffold p7560 was prepared from M13 phage using a previously 
reported method. A 16HB rod was designed in caDNAno, based on a 4x4 square lattice 
cross-section. To synthesize 16HB, a 10-fold excess of staple strands were mixed with 
p7560 scaffold strand (10nM) in folding buffer (5mM Tris, 1mM EDTA, 10mM MgCl2) 
with a total volume of 50µL. The mixture was denatured at 85°C for 10 minutes, followed 
by a slow anneal from 60°C to 25°C over 18 hours (-1°C/30 minutes). 16HB were purified 
from excess staples using agarose gel electrophoresis (0.67%) in 0.5×TBE+Mg buffer (45 
mM Tris, 45 mM Boric acid, 1 mM EDTA, 10 mM MgCl2). AlexaFluor647 imaging 
strands were subsequently added at 32x excess and the mixture was incubated at room 
temperature for at least 3 hours before experiments. 16HB structures were characterized 





5.4.1.6 Particle Translocation Powered by RNase H 
Initially, RNA-substrate surfaces were washed with 5 ml of PBS to remove excess 
unbound RNA. Next, DNA Origami structures were hybridized to the RNA substrate. 
Briefly, 1 µl of purified DNA Origami particles were diluted with 1X RNase H buffer to 
10pM concentration. 50 uL of that solution is was added to the RNA substrate. 
Hybridization between the particles and the complementary RNA monolayer occurred over 
an incubation period of 2 minutes. After hybridization, excess 16HBs and unbound 
imaging strands were washed using 1 mL of RNase H buffer. Then a solution of tetraspek 
beads was added. The unbound beads were washed with 1 mL of RNase H buffer. After, 
particle translocation was initiated by buffer exchange with 100 µl of RNase H reaction 
buffer (25 mM Tris pH 8.0, 8 mM NaCl, 37.5 mM KCl, 1.5 mM MgCl2, 10% formamide 
and 0.75% (g ml–1) Triton X, 1mM DTT) and different concentrations of RNase H from an 
enzyme stock of 7.2 µM enzyme.  
5.4.1.7 Image Processing  
Image processing was performed in MATLAB 2016a (MathWorks) and in Picasso 
[177], a software that is freely available via the Jungmann lab website. The bioformats 
toolbox enabled direct transfer of Nikon Elements image files (.nd2) into the MATLAB 
environment. The search area was set to 3 pixels (= 402 nm). The net movement of all 
fiducial markers in the field of view was subtracted from walker trajectories using a 
custom MATLAB script to account for x–y stage drift. A given trajectory was used in 
subsequent analysis only if the following conditions were met: was in range of cut off 
for detection as described by fluorescent signature of 16 helix bundles, lasted 30 minutes 
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(60 frames) without photobleaching, exhibited no sudden fluorescence intensity changes 
as determined by manual inspection of the output from PICASSO fitting, showed no 
evidence of multiple particles present in one trajectory, and fit to log-log equation with 
an R2 greater than 90%. Calculation of MSD was performed as follows: the position of 
particle is defined as a moving average of 5 subsequent position measurements to reduce 
lateral noise, and the distance of each lag time was then calculated and average and fit to a 
log-log function only taking into account 80% of the data in each trajectory.  
5.5 Results and Discussion 
5.5.1.1 Design and Synthesis of DNA Origami Motors 
The DNA origami motor was designed on a square lattice, consisting of 16 double-
stranded helix bundles (16HB) linked together to produce a rectangular prism with 
dimensions ca. 10 nm x 10 nm x 130 nm, and was assembled by annealing a mixture of 
short synthetic 'staple strands' with a long 'scaffold' strand (Figure 5-1). More details about 
the design and synthesis of this structure can be found in Section 3.4. We incorporated 16 
cargo-carrying strands on the ends of the 16HB, which we used here to bind AF647 
fluorescent dyes to facilitate single-particle tracking. Staple strands with break points on 
the surface of the rectangular prism were extended with ssDNA legs containing ‘motor 
domains’ capable of hybridizing to RNA strands attached to a glass surface. There are 36 
staples on each face, providing a maximum of 144 motor domains which can bind to RNA 
footholds and facilitate adherence to the surface and subsequent locomotion. We can 
selectively modify which staples contain the motor domains, providing unprecedented 
control over anisotropic binding behavior of these motors. For example, we can place 
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motor strands only on specific faces of the 16HB, allowing for control over the distance 
between footholds around the circumference of the motor (geometric mutants). This 
facilitates testing the hypothesis that rolling is the primary mechanism of locomotion, as 
an increased distance between bound footholds on one face and free footholds on other 
faces should inhibit new strand binding and subsequent rolling. We can also selectively 
modify staples on the DNA origami motors in order to understand how the density and 
polyvalency of motor domains impacts rolling behavior. For example, we can eliminate 
select motor domains along the length of the 16HB to alter the local density – by moving 
from a total of 36 strands down to 24 and 12, we can tune the density from 6 to 4 to 2 
strands/200 nm2.We can also alter the number of motor domains while maintaining a 
constant density by decreasing the number of staples along the length of the 16HB which 
contain motor domains, maintaining a constant motor domain density (6 strands/200 nm2) 
but varying polyvalency from 36 strands/face down to 18 and 9 strands. We also were able 
to create variations within these groups – for example, separating the 18-strand design into 
2 9-strand regions. We developed a nomenclature for identifying these variant structures 
in which the number of sides containing extensions is listed first (i.e. 16HB1 for 1 side, 
16HB4 for 4 sides), followed by the number of strands on each face (i.e. 16HB4-36 for full 




Figure 5-1. Design of 16HB DNA Origami Motor. A) 3D model of 16HB motor showing 
DNA origami body (grey), RNA-binding motor domains (green) and fluorescent-dye cargo 
strands (red). B) Representative TEM image of 16HB DNA origami motors with high 
magnification inset. Scale bar - 100 nm. C) Top down view of 16HB face showing possible 
location of all 36 motor domains. D) Variations in motor domain density with either 24 or 
12 strands per face. E) Variations in motor domain polyvalency with constant density, with 
18 strands in two different orientations or 9 strands. 
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 These variant 16HB motor were prepared by swapping out staple strands containing 
the motor domain extensions with those lacking any extensions (a full list of all staples and 
their categorization used in this study can be found in the appendix). Following annealing, 
we analyzed each variation using both TEM and agarose gel electrophoresis. We found 
that there were no observable differences in the core structure of the 16HB regardless of 
the nature of the motor domain extensions, as seen on TEM images (data not shown). 
However, we did find differences in electrophoretic mobility that were dependent upon the 
number of motor domains that were present. For geometric mutants, increasing the number 
of sides which contained the RNA-binding extensions led to a concomitant decrease in 
mobility (Figure 5-2). Similarly, a decrease in mobility accompanied an increase in the 
number of extensions for the polyvalency mutants as well as for density mutants. This is 
consistent with the idea that ssDNA extensions from the surface of the particle increase 
both the overall size of the 16HB as well as the drag experienced during electrophoresis, 
thus leading to reduced mobility. 
 
Figure 5-2. Assembly of Variant 16HB DNA Origami Motors. AGE of 16HB DNA 
origami motors with different motor domain distributions. M - 1kB DNA marker, S - p7560 
scaffold. A) Geometric mutants with 36 motor domains on different numbers of sides B) 
Polyvalency mutants with all 4 sides modified with different strand patterns. C) Density 




 We were also interested in designing structures to help us understand how the 
rigidity of the DNA motors and subsequent cooperativity between individual motor 
domains would affect motor behavior. In order to test this, we purposefully designed 
flexible 16HB structures in which a set number of staple strands were removed from the 
center of the design – this leads to the formation of two separate 16HB units connected 
together by 16 short ssDNA scaffold domains (Figure 5-3). We altered the number of 
staples removed to create two designs with either an 8-nt or a 32-nt ssDNA gap region and 
used AGE and TEM to characterize these structures. We found that the mobility of the 
flexible 16HB was decreased relative to control 16HB motors, and that the structures 
exhibited significant bending as imaged via TEM. The decreased mobility observed for the 
flexible structures is likely due the increased resistance experienced while moving through 
the agarose gel due to the loss of the streamlined profile exhibited by the standard 16HB 
rod. We analyzed the relative distribution of angles observed from TEM for the two 
different designs in order to try to quantify their flexibility – we found that the 32bp gap 
design did have significantly higher flexibility than the 8bp gap design as demonstrated by 









Figure 5-3 Assembly of Flexible 16HB Motors. A) Schematic showing two 16HB halves 
split by 16 ssDNA scaffold segments of either 8nt or 32nt lengths. B) Section of caDNAno 
file showing 8-nt gap design. C) AGE of 16HB motors with gaps. M - 1kB DNA marker, 
S - p7560 scaffold, C - Full 16HB motor. D) Average angle between each arm of the 16HB 
motor for the control full motor (blue), motor with 8-nt gap (red) and motor with 32-nt gap 
(green). N>100, mean ± s.d., * p < .05. E,F) Representative TEM images with high 




5.5.1.2 Characterization of DNA Origami Motor Motion 
The track for 16HB locomotion consists of a glass surface coated with an RNA-DNA 
chimera. The RNA sequence is single-stranded, allowing it to bind to complementary DNA 
sequences via Watson-crick base pairing. The RNA strand is covalently modified with a 
Cy3 fluorescent dye, facilitating the visualization of RNA surface coverage during the 
experiments. Following motor strand hybridization to the RNA track, the activity of RNase 
H selectively cleaves the RNA portion of the RNA/DNA duplex, altering the energy state 
of the motor (Figure 5-4). This change encourages binding of new motor domains to the 
remaining RNA track strands on the surface through a burned-bridge Brownian ratchet 
mechanism - the motor can then roll as a means of bringing new DNA motor domains into 
contact with the RNA surface. 
 
Figure 5-4. Schematic of 16HB Locomotion. RNase H cleavage of RNA in RNA/DNA 
duplexes induces motion of the 16HB through a burned-bridge Brownian ratchet 
mechanism. Degradation of Cy3-tagged RNA leads to the appearance of a depletion track 




Incubation of the DNA origami motors onto the RNA surface leads to the 
appearance of bright spots in the AF647 channel corresponding to the 16HB, showing that 
the motors bind to the surface (Figure 5-5). Control experiments using DNA origami 
structures without motor binding domains or surfaces lacking RNA strands do not show 
the appearance of the spots, pointing to RNA/DNA duplex formation driving 16HB surface 
binding (data not shown). Upon addition of RNase H into the solution, the spots 
corresponding to DNA origami motors begin to move and a concomitant decrease in Cy3-
lebeled RNA surface coverage is observed, consistent with RNase cleavage of the RNA 
substrate. Single particle tracking of the 16HB motor was accomplished by fitting a 
Gaussian curve to the point-spread function of a single origami and tracking the centroid 
of the Gaussian over time. The individual data points were smoothed to remove lateral 
noise and the path of the 16HB could be fit to this data, with the color along the path 
indicating time of localization. Using this same procedure for multiple particles within the 
field of view enabled the visualization and analysis of a large population of individual DNA 










Figure 5-5. Single-Particle Tracking of 16HB Motor Movement. A) Single-particle 
fluorescent images of 16HB motor at different time points, with image of 16HB (top), RNA 
fuel (middle) and merged image (bottom). Path of 16HB movement was over-laid on top 
of image. B) Localizations of a 16HB from A) over time and fit of path taken color-coded 







One technique for analyzing molecular motion is to plot the mean squared 
displacement (MSD) against time. MSD is known to be proportional to tα, where α is a 
scaling factor which can be used to identify the type of motion[178]. An α value of 1 is 
consistent with standard Brownian motion, while an α value less than 1 implies a sub-
diffusive regime where motion is hindered and an α value of greater than 1 implies a 
super-diffusive regime, such as self-avoiding (α ~1.5) or ballistic (α ~ 2) motion. 
Because the motion of our 16HB motors should be biased away from the consumed RNA 
substrate and towards new regions that had not been previously sampled, we 
hypothesized that this motion would be in the super-diffusive regime. We plotted MSD 
vs time for a single 16HB and fit the data to an exponential function to calculate the α 
coefficient. Most of particles demonstrate an alpha coefficient greater than 1.7 which is 
indicative of super-diffusive motion. Furthermore, we calculated a directionality 
coefficient for the motion of origami structures over time, defined as the ratio of net 
displacement over total distance travelled. For Brownian motors this coefficient over 
120 steps is 0.08 but was 0.2 for our 16HB DNA origami motors (data not shown). This 
was suggestive that these origami structures are rolling and not walking or sliding, as 
rolling should theoretically produce more linear motion.  
The AF647-generated tracks match the wide-field Cy3 depletion tracks, which 
confirm that particle motion was associated with continual RNA hydrolysis. Structured 
illumination microscopy (SIM) was used to estimate the width of the depletion tracks, with 
an average full width half max (FWHM) of 133 nm, which closely matches the dimensions 
of the 16HB motor (data not shown), 
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We then sought to find conditions which would optimize motor processivity. We 
found that imaging solution conditions play a significant role in determining overall 
motor activity. For instance, the introduction of formamide, a denaturant which 
enhances RNase H activity and destabilizes dsDNA, led to significant enhancement in 
motor speed, processivity, and overall displacement (vide infra). We also sought to 
identify how enzyme concentration would affect 16HB motor activity (Figure 5-6). In 
the absence of any enzyme we did not see any significant motion from the motors, 
confirming that RNase activity is needed to destabilize existing DNA/RNA interactions 
and induce movement. As the enzyme concentration increased motility of the 16HB 
motors increased, with significant displacement occurring at 28.8nM RNase H and 
further processivity observed at 43.2nM. However, enzyme concentration did not have 
an impact on the mechanism of motion, as the alpha coefficient was the same in all 
conditions. The increase in 16HB MSD with increasing enzymatic concentrations 
confirms that RNase H activity is inducing motor translocation, as higher enzyme 
concentrations leads to faster RNA substrate turnover and faster koff rates for the 16HB 









Figure 5-6. Effect of RNase H Concentration on 16HB Motor Movement. A) Over-lay 
of displacement of many 16HBs with starting point normalized to (0,0) in the presence 
(left) and absence (right) of RNase H. B) Box-whisker plot of net displacement of 16HB 
motors at different RNase H concentrations. C) Box-whisker plot of α values for 16HB 








5.5.1.3 Interrogating Mechanism of Motion with Geometric Mutants 
To confirm the hypothesis that the mechanism of translocation of these origami 
nanostructures is indeed rolling and not walking, we created a library of origami structures 
with anisotropic display of RNA-binding domains across the 4 faces of the rectangular 
prism (‘geometric mutations’) (Figure 5-7). Structures were designed with between 1-4 
faces modified with all 36 motor domains. For the 16HB2 design, we created two different 
isoforms - one in which the two modified sides were adjacent to each other (16HB2Cis-36) 
and two opposite each other (16HB2Trans-36). If motion primarily occurs through a 
walking/sliding mechanism, then motion should be identical as long as one face of the 
16HB displays motor domains. However, if the major mechanism of motion is rolling, then 
16HB with motor domains on multiple sides should show increased motility.  
In our initial experiments, we found that only the 16HB4-36 structure exhibited any 
sustained motion, as it was the only structure with MSD significantly greater than the no-
enzyme control. When imaging conditions more permissive of motor translocation were 
used (due to the introduction of formamide) all 5 motors showed significant displacement 
relative to no-enzyme controls. However, even in this permissive state, evidence of rolling 
behavior was still apparent. 16HB1-36 and 16HB2Cis-36, the two 16HB motors with the 
largest distance between neighboring motor domain-modified sides, showed motor 
behavior that was more consistent with general Brownian diffusion (α = 1) than the super-
diffusive directed motion seen with the other three structures. Furthermore, 16HB1-36 and 
16HB2Cis-36 also exhibited the least processive movement with the smallest MSD relative 




Figure 5-7. Analysis of Motor Behavior Using Geometric Mutants. A) 3D model of 
cross-section of 16HB geometric mutants showing distribution of motor domains. B,C) 
Over-lay of displacement of many 16HBs with starting point normalized to (0,0) for each 
design in the B) absence and C) presence of formamide. D,F) Box-whisker plot of α values 
for 16HB motors with different geometric mutations in the D) absence and F) presence of 
formamide.  E,G) Box-whisker plot of net displacement for 16HB motors with different 
geometric mutations in the E) absence and G) presence of formamide. ns, p > .05, * p < 
.05 compared to -RNase H control, # p<.05 compared to 16HB4-36.   
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 It is interesting that in permissive environments the geometric mutant structures 
were able to exhibit motion, as we had expected that the rolling motion would be required 
for significant displacement. 16HB2Trans-36 and 16HB3-36 both exhibited motion comparable 
to that of the full 16HB4-36 despite the fact that one or more sides were blank. We attribute 
this to the fact that there is likely some flexibility in the region of space which the ssDNA 
motor domains can sample, such that there is the possibility for strand to "wrap around" 
and bind to free RNA domains even when present on the top of the structure. This wrap 
around allows these structures to still participate in the rolling motion. For the 16HB1-36 
and 16HB2Cis-36, the distance between neighboring motor regions is much larger (or non-
existent) which hinders or prevents his phenomenon. As such, these motors cannot 
participate in rolling and thus display a slower crawling/walking behavior. 
5.5.1.4 Design Parameters Affecting Motor Behavior 
Having demonstrated that these DNA origami motors are capable of processively 
converting chemical energy to mechanical motion through a cog-and-wheel translocation 
mechanism, we next sought to further analyze parameters governing this rolling motion. In 
particular, we were interested in investigating the relative effects of the total number of 
DNA legs (polyvalency) vs the relative spatial distribution of these legs (density). We 
created a library of DNA origami structures which decoupled polyvalency/density, such 
that different numbers DNA legs could be non-uniformly distributed along the surface of 
the motors (Figure 5-8). This allowed us to create motors with different polyvalency but 
constant density (16HB4-9, 16HB4-9+9, 16HB4-18) and those with lower density (16HB4-12, 
16HB4-24). While all motors did show processive movement along the RNA-coated surface, 
there were some small differences between the groups. In general, it appears that all 
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structures still exhibit rolling motion, with comparable α values indicating super-diffuse 
motor behavior. The structure with the split binding domain (16HB4-9+9) demonstrated the 
smallest α coefficient, which could be contributed to loss of coherence between the two 
different domains. Correspondingly, this structure also exhibited decreased MSD relative 
to the control 16HB. The 16HB motor with the lowest density (16HB4-12) also exhibited 
decreased mobility despite having a similar α value. This is consistent with data obtained 
using imaging conditions without formamide, in which structures with decreased density 
had decreased mobility. We hypothesize that this is due to decreased relative motor domain 
density relative to RNA strand density, which we approximate to be ~4.5 strands/200 nm2. 
If the motor domain density drops below this (as with the 2 strands/200 nm2 of 16HB4-12), 
motor strands can bind to adjacent DNA strands within the same vicinity after RNase H 
activity. It is only after all the RNA has been cleaved beneath the 16HB that sampling of a 
new region of RNA via rolling can occur. On the other side of the spectrum, 16HB4-9 -
showed the largest and most consistent MSD. This could be due to the fact that less RNase 










Figure 5-8. Effect of Motor Domain Distribution on Locomotion. A) 3D models (top) 
and over-lay of displacement of many 16HBs with starting point normalized to (0,0) 
(bottom) for 16HB with different motor domain placement. B) Box-whisker plot of α 
values for 16HB motors with different motor domain placement C) Box-whisker plot of 
net displacement for 16HB motors with different motor domain placement. ns p > .05, # p 
< .05 compared 16HB4-36 control * p< .05. 
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Finally, we hypothesized that increased flexibility of the 16HB could limit 
movement. We used the 16HB motors which had staple strands removed, producing a 
ssDNA region which led to increased flexibility within the structure (Figure 5-9).  We 
found that these DNA origami motors still exhibited processive motion. However, these 
structures had smaller α coefficients and decreased MSD relative to the rigid 16HB motors, 
which implies that rigidity of the motor plays a role in mechanism of motion. This reduced 
motion could be due to a loss of coherence between motor domains on either end of the 
gap – if one region attempts to move in one direction while the other half moves in another, 
the overall directionality and velocity of the motors could be decreased.  
 
Figure 5-9. Effect of 16HB Motor Flexibility on Locomotion. A) Representative TEM 
images of flexible 16HB motors with either 8-nt (top) or 32-nt (bottom) gaps. Scale bar - 
200 nm. B) Over-lay of displacement of many 16HBs with starting point normalized to 
(0,0) of 16HB motors with either 8-nt (top) or 32-nt (bottom) gaps. C) Box-and-whisker 
plot of fit alpha values for 16HB motors with 8-nt, 32-nt or no gaps.  D) Box-and-whisker 




5.6 Conclusions and Future Directions 
We have created the first DNA origami motor which processively converts chemical 
energy into mechanical motion and the first nanoscale motor to exhibit the cog-and-wheel 
rolling behavior. These motors are processive over multiple hours and can move micron-
scale distances with max velocities of 200 nm/min, significant improvements over 
canonical DNA molecular motors. The DNA origami motors also are the first to display 
autonomous, directed motion in the absence of external factors, such as magnetic fields or 
track patterning. By taking advantage of the unique addressability of DNA origami, we 
were able to provide evidence that the primary mechanism of motion is this rolling 
behavior and not walking through the selective engineering of geometric mutants. We were 
also able to investigate how various physical properties of the motor affect their 
locomotion. The kinetics of these DNA origami motors is related to the density of motor 
domains and is likely related to the relative density matching between these domains and 
the RNA track - if RNA strands are present in higher abundance than DNA strands the 
motor displacement is decreased.   Additionally, it appears that localizing motor domains 
to a smaller region at a constant density leads to enhanced motor efficiency. Finally, the 
rigidity of the DNA motor is an important factor in determining directed motion, as 
structures with engineered flexibility exhibited diminished directionality and kinetics. The 
insights gleaned from this study will help to facilitate the design of the next generation of 
molecular motors with enhanced processivity, directionality, and velocity. These motors 
are promising for use in a number of applications, including DNA computing, biosensing, 
and molecular robotics.  
 
 151 
 Future work should first be focused on validating that the same behavior is 
observable with other DNA nanostructures, and not just the 16HB rod. The design of new 
structures will also allow us to further validate the effect of density and polyvalency 
observed here, along with the investigation of new factors. For example, it would be 
interesting to see how the shape of the DNA origami motors impacts locomotion - how 
would using rods with different diameters alter the kinetics and directionality? Would the 
use of spherical particles rather than rods alter the directionality that was observed? Future 
work should also be directed to developing applications for these motors. Given that we 
already have designed strategies for carrying cargo, it would be interesting to show the 






APPENDIX A. CADNANO DESIGN FILES AND STRAND LIST 
A.1 16HB Design for IONP Binding 
Figure A.1: Schematic of 16HB staple extension design showing 12 binding sites of 3 
strands each. 
 
Figure A.2: caDNAno Design of 16HB: (staples colored in red correspond to binding sites 
on side 1, blue for side 2, green for side 3, and yellow for side 4). Grey strands correspond 
to staples without 5’ extensions on the faces of the 16HB, while the long blue strand 
corresponds to the p7560 scaffold. 
 
Figure A.3: Design of 16HB Dimerization Strands: Dark blue – bridging strands with 5bp 







A.2 16HB Design for Molecular Motor 
Figure A.4: 16HB caDNAno files for 16HB molecular motor. Blue: p7560 scaffold 
strand. Red – Cargo-carrying strands. Grey – Unmodified Staple. Green – Staple 










A.3 16HB Staple List 
Start End Sequence 
0[71] 5[71] AATAGTGACAAGACAAAATTCTGTTCGAGCCA 
0[103] 5[103] CGATAGCTATCGTCGCACAAAATCGAATTATT 
0[135] 5[135] TTTGATTACACTTGCCGAATGGCTTGGCCAAC 
0[167] 5[167] ATCACGCAGCCTTGCTGGTTAAGAAAGCGTTG 
0[199] 5[199] AACCGTCTAGAGTCCAATTAATGATCTTTTCA 
0[231] 5[231] ATATGATACTAGCTGAGAGTAACAGCATTAAA 
0[263] 5[263] GAGAAAGGTATTTTTGGTAGCCAGTAACCAAT 
0[295] 5[295] TGAGTAATTCGGTTGTATTGCTGAGTAGCTCA 
0[327] 5[327] TTAGAACCTACTTTTGAGAGGTCAGTACGGTG 
0[359] 5[359] CCGATAGTATGACAACCTCATCTTAAATACGT 
0[391] 5[391] CTTTCGAGATATTCGGAGGCGAAATAAAAGTT 
0[423] 5[423] GGAGCCTTAGCGGAGTTGCTCAGTTGTATCAC 
3[48] 5[63] CCGGAATCATAATTACTTAATTTCAGGCATTT 
3[80] 5[95] TAATTACATTTAACAAGTGAATAAAAGGAGGC 
3[112] 5[127] TTTTTTAATGGCATGGACGCTAAAGGACATTC 
3[144] 5[159] ACGCTCAATCGTCTGACAATATTATGACCTGA 
3[176] 5[191] TTGCCCCAGCAGGCGAAATAGCCCGTGGTTTT 
3[208] 5[223] TGGTTCCGAAACGTAAGTAATTCGTAAAATTC 
3[240] 5[255] ATATGTACCCCGGTTGGAGTCTGGTCATTTTT 
3[272] 5[287] TCAATAACCTGTTTAGAGCCTCAGATAATGCT 
3[304] 5[319] GGCGCGAGCTGAAAAGCAAGGCAACAACTAAA 
3[336] 5[351] TAATAGTAGTACAGCAACCCTGCAAACGGGTA 
3[368] 5[383] GAACGAGGGTAGCAACAGGGAGTTCACCAACC 
3[400] 5[415] ACTGAGTTTCGTCACCATTTTCTGGGAATAGG 
12[55] 9[55] GAGCGTCTTTGTTTAACTAAGAACTCATCGTA 
12[87] 9[87] TTCCTGATTTACAGAGCAAAATCAAAGCAAAT 
12[119] 9[119] TAACCACCAGAAATAGCTGAATAAAGAAATTG 
12[151] 9[151] TTATCTAAATTTGAGGCTTGCTGAGTGCCACG 
12[183] 9[183] ATTTCTCCGTAAGCAACGTAATCATGTTTCCT 
12[215] 9[215] GACTGAATGGCCTGGCGACGGAGGATTCCACA 
12[247] 9[247] CCAGGGTTGCCAGGGTGCTGCGCACTCCAGCC 
12[279] 9[279] GTAAGAGCATTCATGCGAAAACCACCGGATCC 
12[311] 9[311] ATACATAACAACATTACCAATACTGAAAACGA 
12[343] 9[343] CAGTTTAGTGAGATGAGGTAATAGGTCTTTAC 
12[375] 9[375] TTACCCAAACCAGAACACAGATGAAGACGGTC 
12[407] 9[407] CCGGAACCTAGCGACACTTGATATATAAATCC 
15[64] 9[79] GAAACAATGAAATAGCACAGGGAACCAATAGC 
15[96] 9[111] AAGCCCTTTTTAAGAATAATTTTAAGAAATAA 
15[128] 9[143] GAACAAAGTTACCAGAAACTCGTACTGCAACA 
 
 155 
15[160] 9[175] GCAATAATAACGGAATCGACAGTGAATATAGC 
15[192] 9[207] ATGATTAAGACTCCTTTTTACGCTCGCTCACA 
15[224] 9[239] GCAAACGTAGAAAATATGTCCCGCAGATCGCA 
15[256] 9[271] AACATATAAAAGAAACTCCTTAGTTTCTGGTG 
15[288] 9[303] ATAAGTTTATTTTGTCGTTGGGAAACAGTTCA 
15[320] 9[335] TCATATGGTTTACCAGTTTAAGAAAAAATCAG 
15[352] 9[367] GCGACATTCAACCGATAACTTTAACGAGGCGC 
15[384] 9[399] AATATTGACGGAAATTTCGATAGCAACAACAA 
15[416] 9[439] TTATCACCGTCACCGATAGCAAGGGGAAAGCGCAGTCTCT 
6[87] 0[72] CGACAAAACATCGGGAGACGCTGAGAAGAGTC 
6[119] 0[104] TTATGAATTGCTTATGATCCTTGAAAACATAG 
6[151] 0[136] CACAGACACGCCATTAGTTGTAGCAATACTTC 
6[183] 0[168] ACGCGCGGGTTGCGCTGTAAAAGAGTCTGTCC 
6[215] 0[200] GATTCGTGACCTGTCTACGTCAAAGGGCGAAA 
6[247] 0[232] AACATTAACCGTAATGAGTCAAATCACCATCA 
6[279] 0[264] CGCGTCTGTTCGAGCTAAAGATTCAAAAGGGT 
6[311] 0[296] GATGGCTTAACTCCAATTTTAAATGCAATGCC 
6[343] 0[328] AGCGCTCCTAATTGATGCAAGGATAAAAATTT 
6[375] 0[360] AGAATACAAACGGAGACTTAAACAGCTTGATA 
6[407] 0[392] GATAAGTGTGCCCCCTTCGGTTTATCAGCTTG 
6[439] 0[424] AGGATTAGGAAACATGAAAAAAGGCTCCAAAA 
11[80] 1[87] ATGATGGCCAAGAAAAAGAATATACCTACTTTAGAAATGC 
11[112] 1[119] TTTGGATTTAATGAGCTTACCAAGCAGTACATAATTTTCC 
11[144] 1[151] AAATCAACATTGGCAGAACCCTTCCCGCCAGCAGAACTCA 
11[176] 1[183] TGAGTAAACCTGAGAGGCGCCAGGGAGATAGGGTTCCAGT 
11[208] 1[215] GTTACCTCTTTCAACAACGGGTGTGCAAAATCGAACGTGG 
11[240] 1[247] GCCAGCTGATAAGCAAAAATCAGCAGCAAACATGCCGGAG 
11[272] 1[279] ATCATAACCATTTCGCCATCAAAAAGCGGCTAACAAAATA 
11[304] 1[311] AACCAAAACGAACGAGTAAATATGAGAATTAGCATTATGA 
11[336] 1[343] GTTTTGCCCCATTCCATTTCATTATTAACATCGCCTTTAT 
11[368] 1[375] AGAGTAATTGAGGACTTACGAAGGAAAGGCCGCCCACGCA 
11[400] 1[407] CAGAGCCGATAGCAAGTATAGCCCTATGGGATAACTTTCA 
11[432] 1[439] GAGCCACCCACCCTCAGGAGGTTTGTCTTTCCAAAGGAAC 
8[79] 2[72] CTTCAATCGAAACTTAGGTAAAGTAGAACGCGTTCAAATA 
8[111] 2[104] TTTAACGTCGCCTGATACCAAGTTTATTAATTAAATCAAT 
8[143] 2[136] AAAACAGATAAAACATATATTTTTTGAGTAGACATTGCAA 
8[175] 2[168] TGAGTGAGTTAATTGCGGAGAGGCGGTGTGTTGTTGAAAT 
8[207] 2[200] GAAGCATAGTCGGGAACCAGCTGCCTATTAAACCTTATAA 
8[239] 2[232] GTTTGAGGCGGATTGAATGTGAGCTAAATTAAAGAGAATC 
8[271] 2[264] TTTATGGGTGTAGTAAGCCTTCCTAGAGATCTTCAGGTCA 
8[303] 2[296] AAGAGGAACGGAAGCAAGAGCTTAACCAAAAACAAAATTA 
8[335] 2[328] TCAGAAGCAGTACCTTTTTTGATACGGGAGAACAATAAAT 
8[367] 2[360] AATCCGCGCAAAGTACCTAAAACAAACCATCGCTTTTGCG 
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8[399] 2[392] GTAACAGTACAGTTAACCGTCGAGTCGTAAACTTTGCCTG 
8[431] 2[424] GGTAATAAATTATTCTCGGGGTTTGAGAATAGAGACGTTA 
10[79] 3[79] GATATAGAGTAATAAGCAATTTAGGCCTGAAT 
10[111] 3[111] TGGAAGGGCATTTCAAAAAAGAAGGAATTACC 
10[143] 3[143] ACCTCAAAAGAGATAGATTCACCAACATTTTG 
10[175] 3[175] TGGTCGAACGTATTGGAGTTGCAGACGCTGGT 
10[207] 3[207] ATCCCCGGCCAGTGAGGCTGATTGTTTGATGG 
10[239] 3[239] ACTGTTGGTTTTTGTTATATTTAATGTCAATC 
10[271] 3[271] GGCAAAGCAGGAACGCAAACCCCAAAAAGTGG 
10[303] 3[303] GCGGAATCACATGTTTTAGATTTATCATTTGG 
10[335] 3[335] TAAAATGTTCTGGAAGTATAACAGAATTCTAC 
10[367] 3[367] ACGGTGTAAATGCCACAAAGACTTCAGCATCG 
10[399] 3[399] TCACATGAGATATAAGCCCAATAGACCGTAAC 
10[431] 3[431] GTTGAGGCCGTACTCAGAGCCACCCTACAACG 
2[71] 4[64] TATTTTAGTAGAAAAATATCATAT 
2[103] 4[96] ATATGTGATTTCATTTATGATGAA 
2[135] 4[128] CAGGAAAAAAATACCTGTCACACG 
2[167] 4[160] ATCCAGAAAATGGTCCCAAGCGGA 
2[199] 4[192] ATCAAAAGAAATCCTGCCCTTCAC 
2[231] 4[224] GATGAACGAACTAGCAATTGTAAA 
2[263] 4[256] TTGCCTGAATAATCAGAAAACAGG 
2[295] 4[288] AGCAATAACTATATTTGTTTGACC 
2[327] 4[320] CATACAGGGTGGCATCTTGATTCC 
2[359] 4[352] GGATCGTCGCGAAAGATTTCATGA 
2[391] 4[384] AGGCTTGCGGCCATGTGAACCTAC 
2[423] 4[416] GTAAATGAAGTACAAAACCCTCAT 
13[72] 11[79] AGCAGCCTTATCTGAATTATCCAG 
13[104] 11[111] CGGAACAAAGAAGGAGCCTGATTG 
13[136] 11[143] GATAATACAATATCTTCAGTTGGC 
13[168] 11[175] TGCCATCTGAACTCTGTGGTGTAA 
13[200] 11[207] AATATAGGCGGCTGACTGGTGCTT 
13[232] 11[239] CAGGAGAATTCCCAGTGCTATTAC 
13[264] 11[271] GGTTGTGAAACAGGCGCTGCAACT 
13[296] 11[303] TAACGGAACGCCAAAAACGATAAA 
13[328] 11[335] TCATCAGTGAATACCACAAAAGAA 
13[360] 11[367] CGAGAAACATCAACGTCTTCATCA 
13[392] 11[399] GTAATCAGAGAGCCACGCCTCCCT 
13[424] 11[431] TAGCGTCAGCCATCTTCACCCTCA 
10[71] 12[56] AGGCTTATCTACAATTTCTTACCAACGCTAAC 
10[103] 12[88] TTAGAACCAATATAATCGGAATTATCATCATA 
10[135] 12[120] TATCAAACTATCTGGTTAGGAGCACTAACAAC 
10[167] 12[152] AAATCTAAGGACTGGTACCTCATTGAGGAAGG 
10[199] 12[184] GTACCGAGAAGCTACGGCATTTCACATAAATC 
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10[231] 12[216] GAAGGGCGGCCTCTTCCACGACGTTGTAAAAC 
10[263] 12[248] GCCATTCGGGGATGTGATTAAGTTGGGTAACG 
10[295] 12[280] GTCATAAAACCAGACGGGAATTACGAGGCATA 
10[327] 12[312] TTAGACTGGGCTTTTGCATTCAACTAATGCAG 
10[359] 12[344] CAGACCAGTGGCTGACAACAAAGCTGCTCATT 
10[391] 12[376] CCAACTTTGAAGAACCCACCGCCGGATATTCA 
10[423] 12[408] AGGTCAGAAGAACCGCTTCATAATCAAAATCA 
7[64] 13[71] AGCATGTAAATAATCGTACCGCGCGCGCATTAATGAAAAT 
7[96] 13[103] AACGGATTCAGATGAACGTAAAACAAAGTTTGTCATTTTG 
7[128] 13[135] GATAGCCCGGTGAGGCAACACCGCTTAAATCCCGTCAATA 
7[160] 13[167] GAATCACACTAACCGACAGCAGCACGGAGACTGTATTCCC 
7[192] 13[199] GCTTTCCAAAGTGTAATTGTTATCCGCCCTGGTGGGCACG 
7[224] 13[231] ACAAACGGGGACGACGCCTCAGGACAAAATAAAGCTTTCT 
7[256] 13[263] CACGTTGGCGCATCGTGGCACCGCGCTGAATTTTCTAAGT 
7[288] 13[295] AACCAGACGCCCGAAATGCTTTAAGAAAAATCAAACGAAC 
7[320] 13[327] GATTAGAGAAAGCGGAATAAATCACTGGCTCAAGAAAGAT 
7[352] 13[359] GCGCGAAAACCTGCTCAGCCGGAATCATTGTGTGCCCTGA 
7[384] 13[391] ATCTATAAGCCCGGCCGGGAACCGAGCGGCTTAATTGACC 
7[416] 13[423] CGGAACCTGTTTTAACGCCAGAATCCGGAAACTTTGCCTT 
4[63] 14[56] GCGTTATAGCACCCAGCCGGTATTCGTCAAAAGACGGGAG 
4[95] 14[88] ACAAACATAATTCATCTACCATATAGACATTAAGTAAATA 
4[127] 14[120] ACCAGTAAATAATCAACCTCACTTATTAGAGCTTTGCCCG 
4[159] 14[152] TTATTTACAGTTGAAAAGCATCACATTTAGAATTACAAAC 
4[191] 14[184] CGCCTGGCCAGGGCTTCTCGAATTCTCGTCGGAGTGACTC 
4[223] 14[216] CGTTAATAGATTGCGGATCGGAAACAGTGCCACCCCGCTT 
4[255] 14[248] AAGATTGTGCGAAAGGCCATTCAGGGATGTTCGTCAACCT 
4[287] 14[280] ATTAGATACCTCGTTTTATTCATTGCATAATATACGTCGA 
4[319] 14[312] CAATTCTGTAGCGAGAGATAGCGTTTACAGGTTTATACCA 
4[351] 14[344] GGAAGTTTAGATAGGCGCGCAGGGATAAGGCTAATTACCT 
4[383] 14[376] AGAGGCTTCTTGACAAGAAAGAGGGAGTAGTAGAGATGGT 
4[415] 14[408] TTTCAGGGCCACCCTCCGATTGGCGAATCAAGGTCACCAA 
6[63] 15[63] CCAGACGAGGAATCATGCTGTCTTAAGAGCAA 
6[95] 15[95] GCGCATACTATTTGCATATACAGTTCTTACCG 
6[127] 15[127] ATTAGTCTCGTGTATTGGTCAAGAAGATAGCC 
6[159] 15[159] ATACGTGGCTGAGAGCACCACCAGGAGGAAAC 
6[191] 15[191] ATCGGCCAGTGTGAAAAGCCTGGGGAACTGGC 
6[223] 15[223] ACCCGTCGCAAATCGGACAGTCATGTATGTTA 
6[255] 15[255] CTTTCATCAGCTTTCCAACCGTGCAAGGTGGC 
6[287] 15[287] ATATAATTCCCTCAAAGACTTCAAACCACGGA 
6[319] 15[319] TTTTTGCGGAATGACCTTGCATCATAGAAAAT 
6[351] 15[351] TGACCCCCCCTTACTTCATGTGACACAAAAGG 
6[383] 15[383] GAGGCAAAAATCATAATGATAAATGGAAGGTA 
6[415] 15[415] ACCAGGCGTCATTAAAGGGGTCAGAAGGTGAA 
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14[55] 8[47] AATTAACTCCAATAATTCCTTATCA 
14[87] 8[80] ACATAAAAAATAGCTAAACAGTAC 
14[119] 8[112] AACGTTATAAGTAAGCTTTTCAGG 
14[151] 8[144] AATTCGACAGGAAACCCAGAAGAT 
14[183] 8[176] TATGATACACCCAAAAGTGCCTAA 
14[215] 8[208] CTAATCTAATTACGCAACGAGCCG 
14[247] 8[240] TATGACAACATACATAATCTGCCA 
14[279] 8[272] CTTAAGTGGCAAAGACATATCGCG 
14[311] 8[304] GTCAGGACACAATCAAAAAAGATT 
14[343] 8[336] TATGCGATCGCCAAAGTATTATAG 
14[375] 8[368] TTAATTTCTGAGGGAGTGTGTCGA 
14[407] 8[400] TGAAACCAATTCATTATGCCTTGA 
1[56] 7[63] TCCAATCGATTTATCAAATTTACG 
1[88] 7[95] TTCTGTAATAGATTAAGAAACAAT 
1[120] 7[127] CTTAACATGTAATAGACGCGAACT 
1[152] 7[159] AACTATCGAATTAACCAAAATACC 
1[184] 7[191] TTGGAACAATCACCGACACTGCCC 
1[216] 7[223] ACTCCGTTTTCAACCACCGTGGGA 
1[248] 7[255] AGGGTAGCCCGGAGACGGATAGGT 
1[280] 7[287] AAGCTAAAGTGTAGGTTCAAAGCG 
1[312] 7[319] CCCTGTAACTCATATACAGGTCAG 
1[344] 7[351] TTCCGACATGCGCAACTATACCAA 
1[376] 7[383] TAACCGATGTGAATTTTTTGTATC 
1[408] 7[415] ACAGTTTCTAATTGTAGCCTATTT 
0[463] 0[440] TTTTTTCACGTTGAAAATCTCCAA 
2[463] 2[440] AGCGTAACGATCTAAAGTTTTGTC 
4[458] 4[440] CCGCCACCCTCAGAACCGC 
6[458] 6[440] ACTCCTCAAGAGAAGGATT 
8[463] 8[440] ATACATGGCTTTTGATGATACAGG 
10[463] 10[440] ACCACCAGAGCCGCCGCCAGCATT 
12[458] 12[435] TCGGTCATAGCCCCCTTATTAGCG 
14[458] 14[435] CAAAATCACCAGTAGCACCATTAC 
1[16] 1[47] TAGGTTGGGTTATATAACTATATGTAAATGCT 
3[16] 3[47] GTGATAAATAAGGCGTTAAATAAGAATAAACA 
5[11] 5[43] TTGAGAATCGCCATATTTAACAACGCCAACATG 
7[11] 7[43] TCAACAATAGATAAGTCCTGAACAAGAAAAATA 
9[16] 9[47] ACTCATCGAGAACAAGCAAGCCGTTTTTATTT 
11[16] 11[47] GGAGGTTTTGAAGCCTTAAATCAAGATTAGTT 
13[11] 13[43] CATATTATTTATCCCAATCCAAATAAGAAACGA 




A.4 Additional Sequences 




CTC TCT CTC TCT CTC TCT CT - DBCO 
IONP 
Capture 
AG AGA GAG AGA GAG AGA GAG – Origami Staple 
Bead 
Anchor 1 
AAA GTC AGA GGG TAA TTG AGC GCT CTG GCT TGC CAA 




AAC GGG TAT TAA ACC AAG TAC CGC CTG GCT TGC CAA AAA 
AAA AAA AA 
Bead 
Anchor 3 
CCA ACG CTC AAC AGT AGG GCT TAA CTG GCT TGC CAA AAA 
AAA AAA AA 
Bead 
Anchor 4 
TTA ATG GTT TGA AAT ACC GAC CGT CTG GCT TGC CAA AAA 
AAA AAA AA    
Release 
Strand 
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